Stay Ahead with the Latest Oncology Insights

Cutting-Edge Science to Real-World Practice

Conferences

View All
Experts Dr. Rahul Gosain, Dr. Rohit Gosain, Dr. Brian Rini, and Dr. Thomas Powles discuss 6 clinical trials on treatment options for genitourinary cancers.

Conferences

07/15/2026

6 Trials Impacting Treatment Options for Genitourinary Cancers

Thomas Powles, MD, MBBS, MRCPBrian Rini, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
Group of three medical professionals, including Dr. Hope Rugo, discussing breast cancer updates from ASCO 2026.

Conferences

07/13/2026

7 Key Breast Cancer Updates From ASCO 2026

Hope Rugo, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
Dr. Rahul Banerjee, Dr. Rohit Gosain, and Dr. Rahul Gosain discuss key updates from EHA 2026 on multiple myeloma trials.

Conferences

07/07/2026

5 Key Multiple Myeloma Trial Updates From EHA 2026

Rohit Gosain, MDRahul Gosain, MD, MBARahul Banerjee, MD, FACP
Dr. Neena Vijayvergia, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing key gastrointestinal trials at ASCO 2026 for clinical practice.

Conferences

07/02/2026

ASCO 2026: Key GI Trials Shaping Clinical Practice

Neena Vijayvergia, MDRahul Gosain, MD, MBARohit Gosain, MD
Dr. Joshua Brody, MD, in front of New York City skyline, discussing Liso-Cel treatment for relapsed DLBCL patients.

Conferences

07/02/2026

Liso-Cel in Relapsed DLBCL: Patient Selection, Outcomes, and Referral Strategies

Joshua Brody, MD
Image featuring Dr. Rahul Gosain, Dr. Rohit Gosain, and Dr. Isabel Preeshagul discussing NSCLC presentations at ASCO 2026 with New York City skyline in background.

Conferences

06/30/2026

4 Major NSCLC Presentations From ASCO 2026

Isabel Preeshagul, DO, MBSRahul Gosain, MD, MBARohit Gosain, MD
Presentation slide showing SARC041 study on CDK4/6 inhibition as a treatment for dedifferentiated liposarcoma with modern cityscape background.

Conferences

06/29/2026

SARC041: Establishing CDK4/6 Inhibition as a New Treatment Option in Dedifferentiated Liposarcoma

Samantha Armstrong, MD
Two medical professionals, Sawyer Bawek and Agrima Mian, discuss lymphoma data at ASCO 2026, with a city skyline background.

Conferences

06/26/2026

ASCO 2026: Key Lymphoma Data From the frontMIND and SUNMO Trials

Sawyer Bawek, DOAgrima Mian, MD
Two medical professionals, a woman and a man, stand in front of a city skyline with a banner reading 'Expanding Precision Therapy in Lung Cancer' for OncUpdates.

Conferences

06/26/2026

The Growing Role of Precision Medicine Across Lung Cancers

Stephen Liu, MDArthi Sridhar, MD
Two female medical professionals, Carolina Bernabe Ramirez and Cathy Eng, MD, FACP, FASCO, standing outdoors in front of a cityscape with a modern building, discussing pancreatic cancer research.

Conferences

06/25/2026

EPISODE-III and RASolute 302 Data From ASCO 2026

Carolina Bernabe Ramirez, MDCathy Eng, MD, FACP, FASCO
Dr. Brendan Guercio and Dr. Tian Zhang discuss perioperative strategies for high-risk localized prostate cancer at ASCO 2026.

Conferences

06/25/2026

Practice-Changing Updates for Prostate Cancer From ASCO 2026

Brendan Guercio, MDTian Zhang, MD, MHS
Dr. Samantha Armstrong, Dr. Rahul Gosain, Dr. Rohit Gosain, and Dr. Ari Rosenberg discuss key ASCO 2026 studies on head and neck cancer and sarcoma.

Conferences

06/24/2026

Key Studies in Head and Neck Cancer and Sarcoma From ASCO 2026

Samantha Armstrong, MDAri Rosenberg, MDRahul Gosain, MD, MBARohit Gosain, MD
Two medical professionals, a male and a female, smiling in front of a cityscape with a fountain, representing networking and mentorship in oncology.

Conferences

06/23/2026

ASCO Benefits for Trainees: Networking, Mentorship, and Career Growth

Sawyer Bawek, DOAgrima Mian, MD
Dr. Michael Serzan and Dr. Sumanta Pal discuss adjuvant immunotherapy in renal cell carcinoma at OncUpdates, with a city skyline and Ferris wheel in the background.

Conferences

06/22/2026

Adjuvant Immunotherapy in RCC: Insights From RAMPART

Sumanta Pal, MD, FASCOMichael Serzan, MD
Two female doctors, Arth Sridhar and Narjust Florez, smiling in front of a city skyline, discussing NSCLC trial updates for HARMONi-6 and LIBRETTO-432.

Conferences

06/22/2026

HARMONi-6 and LIBRETTO-432: Major Trial Updates for NSCLC Subtypes

Arthi Sridhar, MDNarjust Florez, MD, FASCO
Two medical professionals discussing Talquetamab monitoring and management strategies in an urban park setting.

Conferences

06/20/2026

Talquetamab Side Effects: Management and Counseling Strategies

Sawyer Bawek, DOHamza Hashmi, MD
City street scene with theater marquee and skyscrapers, highlighting recent advances in GU cancers from ASCO 2026.

Conferences

06/19/2026

Practice-Changing Shifts in GU Cancers From ASCO 2026

Jesus Gomez, MDManas Pustake, MD
Dr. Brian Wolpin and colleagues discuss groundbreaking data for Daraxonrasib in mPDAC from the Phase 3 RASolute 302 Trial.

Conferences

06/18/2026

Phase 3 RASolute 302 Trial: Groundbreaking Data for Daraxonrasib in mPDAC

Brian Wolpin MD MPHRahul Gosain, MD, MBARohit Gosain, MD
Two medical professionals, a young woman and an older woman, standing in front of a cityscape with a river, discussing evolving hepatocellular carcinoma treatments.

Conferences

06/18/2026

Evolving HCC Treatment: Combining Immunotherapy and TACE

Antonella Cammarota, PhDLorenza Rimassa, MD
Cityscape with river and skyscrapers, highlighting new cancer treatment developments in head and neck cancer research.

Conferences

06/17/2026

From Resistance to Response: Amivantamab Opens a New Chapter in Head and Neck Cancer

Coral Olazagasti, MD
Two medical professionals, Sawyer Bawek and Hamza Hashmi, discuss Teclistamab in earlier treatment lines for multiple myeloma with a city skyline background.

Conferences

06/17/2026

MajesTEC-9 Data and Teclistamab in Earlier Treatment Lines for Multiple Myeloma

Sawyer Bawek, DOHamza Hashmi, MD
City skyline with water and text about GU experts on bladder, kidney, and prostate cancer trials.

Conferences

06/17/2026

GU Experts Weigh In on Trials That Could Redefine Bladder, Kidney, and Prostate Cancer Care

Andre Kydd, MD, PhD
Two medical professionals, Sawyer Bawek DO and Hamza Hashmi MD, discuss the evolution of CAR T-cell therapy against a cityscape background.

Conferences

06/16/2026

The Growing Role of CAR T-Cell Therapies in Multiple Myeloma

Sawyer Bawek, DOHamza Hashmi, MD
Image showing the ASCO 2026 conference banner with the study title on a city skyline background, highlighting advancements in multiple myeloma treatment.

Conferences

06/16/2026

ASCO 2026: Mezigdomide Plus Kd Doubles PFS in Heavily Pretreated Multiple Myeloma in SUCCESSOR-2

Sawyer Bawek, DO
Aerial view of New York City skyline with river and park, highlighting advancements in pancreatic cancer treatment.

Conferences

06/15/2026

Daraxonrasib Delivers Game-Changing Survival Benefit in Previously Treated PDAC

Sunnie Kim, MD
RASolute 302 study evaluating the side effect profile of Daruxonasib with Dr. Raji Shameem and Dr. Shiraj Sen in an urban park setting.

Conferences

06/15/2026

RASolute 302: Evaluating the Side Effect Profile of Daraxonrasib

Shiraj Sen, MD, PhDRaji Shameem, MD
Visual representation of integrating circulating tumor DNA (ctDNA) into muscle-invasive bladder cancer treatment strategies, with a city skyline background.

Conferences

06/14/2026

Integrating ctDNA Into Muscle-Invasive Bladder Cancer Treatment

Miles Hsu, MD
Insights from ASCO 2026 on antibody-drug conjugates reshaping metastatic triple-negative breast cancer treatment.

Conferences

06/14/2026

Insights from ASCO 2026: Antibody–Drug Conjugates Continue to Reshape Metastatic Triple-Negative Breast Cancer

Stephanie Haddad, DO
HPV-negative head and neck squamous cell carcinoma research, treatment strategies, and clinical insights by Nicole Dalal, MD, and Fangdi Sun, MD.

Conferences

06/13/2026

Emerging Data on Amivantamab and Other Anti-EGFR Bispecifics in Head and Neck Cancer

Nicole Dalal, MDFangdi Sun, MD
Healthcare professionals Alexis LeVee, MD, and Hope Rugo, MD, FASCO, discuss community perspectives on ADCs and novel agents in triple-negative breast cancer (TNBC).

Conferences

06/12/2026

Breast Oncologists Discuss the Current Paradigm and Future Advancements for ADCs in TNBC

Alexis Levee, MDHope Rugo, MD, FASCO
Molecular profiling and treatment sequencing in HR-positive breast cancer with Dr. Ya Haddy Sallah and Dr. Jimmitti Teysir.

Conferences

06/12/2026

How Molecular Profiling Guides Targeted Therapy Options in HR–Positive Breast Cancer

Jimmitti Teysir, MDYa Haddy Sallah, MD, MPH
Overview of GLP-1 receptor agonists and their role in breast cancer treatment, featuring insights from Cleveland Clinic expert Jasmin Hundal, MD, MS, MPH.

Conferences

06/11/2026

GLP-1 Receptor Agonists in Breast Cancer: Moving Beyond Weight Loss Toward Cancer Prevention and Survivorship

Jasmin Hundal, MD
Experts discuss innovative treatment strategies for metastatic ER-positive breast cancer against a city skyline at sunset. Focus on oncology, breast cancer, and advanced therapies.

Conferences

06/11/2026

How To Approach Endocrine Therapies for Metastatic Breast Cancer in the Adjuvant CDK4/6 Inhibitor Era

Jasmin Hundal, MDDionisia Quiroga, DO, PhD
Medical professionals discussing considerations and clinical trials for early-stage breast cancer treatment.

Conferences

06/10/2026

Oncologists Consider Potential Roles of ADCs in Early-Stage Breast Cancer Treatment

Alexis Levee, MDHope Rugo, MD, FASCO
ASCO 2026 presentation on Giredestrant for ER+/HER2- metastatic breast cancer at Roswell Park Cancer Center.

Conferences

06/10/2026

ASCO 2026: Evaluating Giredestrant in First-Line ER+/HER2- Metastatic Breast Cancer

Vaishali Deenadayalan, MD
Two doctors discussing zanidatamab-based treatment options for HER2-positive gastric cancer against a city skyline background.

Conferences

06/10/2026

HERIZON-GEA-01 Updates and Sequencing HER2-Directed Treatments in Gastric Cancer

Geoffrey Ku, MDSteven Maron, MD, MSc
Two medical professionals, Joseph McCollom, DO, and Rachna Shroff, MD, MS, FASCO, discuss the latest updates on upper gastrointestinal cancer care at the Matterhorn conference.

Conferences

06/09/2026

GI Oncologists Discuss MATTERHORN Updates and Challenging HCC Subgroups

Joseph McCollom, DORachna Shroff, MD, MS, FASCO
Experts Alexis LeVee, MD, and Hope Rugo, MD, discuss optimizing ADC selection for metastatic triple-negative breast cancer treatment.

Conferences

06/09/2026

The Current Paradigm for Selecting and Sequencing ADCs in Metastatic TNBC

Alexis Levee, MDHope Rugo, MD, FASCO
Two medical professionals, Deepak Vadehra, DO and Charbel Matar, MD, discussing RASolution 302 and targeted therapy for gastrointestinal cancers in an urban setting.

Conferences

06/09/2026

Experts Review Groundbreaking Data From RASolute 302 and Its Impact on GI Oncology

Charbel Matar, MDDeepak Vadehra, DO
Key ASCO 2026 updates on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) presented at OncUpdates, highlighting recent advancements and research findings.

Conferences

06/09/2026

Key ASCO 2026 Updates in NSCLC and SCLC

Chinmay Jani, MDTessa Lavorgna, MD
Two medical professionals, Dr. Rohit Gosain and Dr. Danai Dima, discuss CAR-T therapy for multiple myeloma in an urban cityscape background.

Conferences

06/08/2026

How Community Oncologists Can Optimize CAR T-Cell Therapy for Patients With Multiple Myeloma

Danai Dima, MDRohit Gosain, MD
Expert discussion on perioperative chemoimmunotherapy for upper gastrointestinal cancer, highlighting recent advances and treatment strategies.

Conferences

06/08/2026

Doctors React to the New Treatment Landscape for Gastric and Gastroesophageal Junction Cancers

Charbel Matar, MDRaji Shameem, MD
Experts discuss personalized adjuvant CDK4/6 inhibitor therapy for breast cancer in a professional conference setting.

Conferences

06/08/2026

How to Select a CDK4/6 Inhibitor in Early or Metastatic Breast Cancer

Giuseppe Curigliano, MD, PhDArya Mariam Roy, MD
Two female doctors, Sarah Premji, MD, and Komal Jhaveri, MD, FACP, discussing biomarker testing for HR-positive metastatic breast cancer against a city skyline background.

Conferences

06/07/2026

Biomarker Testing and Targeted Therapy Advancements in Metastatic Breast Cancer

Komal Jhaveri, MD, FACPSarah Premji, MD
Zanidatamab emerging as a potential new standard of care in oncology, featuring Dr. Shruti Patel and Dr. Tanios Bekaii-Saab discussing innovative cancer treatment options.

Conferences

06/07/2026

Transformational Data From HERIZON-GEA-01 and RASolute 302 for GI Malignances

Tanios Bekaii-Saab, MDShruti Patel, MD
Aerial view of a city skyline with a waterfront, highlighting the latest insights from ASCO 2026 on evolving treatment strategies for gastrointestinal cancers.

Conferences

06/07/2026

Insights From ASCO 2026: Evolving Treatment Strategies in Gastrointestinal Malignancies

Aslihan Yerlikaya, MD
OncUpdates episode featuring discussions on bringing Mezidomide into clinical practice, focusing on efficacy, safety, and implications for oncology treatment.

Conferences

06/07/2026

Bringing Mezigdomide Into Practice: Efficacy, Safety, and Clinical Implications

Paul G. Richardson, MDRahul Gosain, MD, MBA
Expert discussion on Mezidomide's mechanism of action and early clinical development, featuring Rahul Gosain and Paul Richardson.

Conferences

06/07/2026

Understanding Mezigdomide: Mechanism of Action and Early Clinical Development

Paul G. Richardson, MDRahul Gosain, MD, MBA
Experts Christine Garcia, MD, MPH, and Rami Manoachakian, MD, discuss innovative small cell lung cancer treatments in a city skyline setting.

Conferences

06/06/2026

Oncologists Highlight Tarlatamab and Other Advancements in SCLC

Chirstine Garcia, MD, MPHRami Manochakian, MD
Dr. Elias Chandran and Dr. Andrea Apolo discuss the latest developments in bladder cancer care, highlighting EV-Pembrolizumab's role in redefining treatment strategies.

Conferences

06/06/2026

The Impact of EV Trials Across Bladder Cancer Populations

Andrea Apolo, MDElias Chandran, MBBS, FRACP
Clinical trial image showing Broke Kania, DO, discussing the Talaporo-3 study on cancer treatment with Talazoparib and Enzalutamide for HRR-mutated mCSPC.

Conferences

06/06/2026

TALAPRO-3: A Major rPFS Win in HRR-Mutated mCSPC, But Which Patients Benefit Most?

Brooke Kania, DO
Experts Dr. Rohit Gosain and Dr. Samer Al Hadidi discuss follow-up data on CAR T cell therapy safety and effectiveness in high-risk multiple myeloma patients.

Conferences

06/05/2026

ASCO 2026 Follow-Up Data Support CAR T Safety and Activity in High-Risk Multiple Myeloma

Samer Al Hadidi, MDRohit Gosain, MD
Experts discuss the significance of adjuvant Durvalumab monotherapy in rapid cancer treatment responses.

Conferences

06/05/2026

MATTERHORN Analysis Upholds Value of Adjuvant Durvalumab Maintenance Period

Samuel Cytryn, MDRutika Mehta, MD, MB, MPH
Overview of the Episode III clinical trial showing aspirin's lack of DFS benefit in stage III colorectal cancer, with a cityscape background.

Conferences

06/05/2026

EPISODE-III Trial: Adjuvant Aspirin Shows No DFS Benefit in Stage III CRC

Young Rho, MD
Overview of six key breast cancer clinical trials presented at ASCO 2026, highlighting advancements in breast cancer treatment and research.

Conferences

06/04/2026

Six Practice-Informing Breast Cancer Trials From ASCO 2026

Nerea Lopetegui-Lia, MD
Overview of EV-302 update on enfortumab vedotin and pembrolizumab improving survival in metastatic urothelial cancer patients.

Conferences

06/03/2026

EV-302 Update: Enfortumab Vedotin Plus Pembrolizumab Maintains Survival Benefit at 3.5 Years in Metastatic Urothelial Cancer

Saad Atiq, MD
Experts discuss new treatment strategies for relapsed and refractory multiple myeloma, focusing on rapid response and expanding therapeutic options.

Conferences

06/03/2026

Rapid Reactions: Expanding Treatment Options in Relapsed/Refractory Multiple Myeloma

Paul G. Richardson, MDRahul Gosain, MD, MBA
Key updates from ESMO Breast Cancer 2026, featuring Dr. Rahul Gosain, Dr. Rohit Gosain, and Dr. Erika Hamilton discussing recent advances in breast cancer trials.

Conferences

05/29/2026

Six Major Trial Updates From ESMO Breast Cancer 2026

Erika Hamilton, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
Overview of thoracic oncology highlights at ASCO 2026, focusing on lung cancer research and treatment updates for oncologists and medical professionals.

Conferences

05/28/2026

What to Watch at ASCO 2026: A Thoracic Oncologist’s Guide to the Lung Cancer Program

Dan Morgenstern, MDChinmay Jani, MDGilberto Lopes, MD
Modern metallic sculpture in an urban setting with skyscrapers, promoting the ASCO 2026 gastrointestinal cancer conference and research updates.

Conferences

05/15/2026

ASCO 2026: Gastrointestinal Abstracts to Watch

Raji Shameem, MD
Advanced medical professionals discussing bladder, kidney, and prostate cancer updates at ASCO GU 2026 conference.

Conferences

03/25/2026

Bladder, Kidney, and Prostate Cancer Highlights From ASCO GU 2026

Petros Grivas, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Bladder, prostate, and kidney cancer updates from ASCO GU 2026, featuring medical professionals discussing recent advancements in cancer treatment and research.

Conferences

03/20/2026

ASCO GU 2026: Key Updates in Bladder, Prostate, and Kidney Cancer

Charbel Matar, MD
Advanced renal cell carcinoma research on HIF-2α inhibition featuring Dr. Michael Serzan and Dr. Toni Choueiri, with a cityscape background, highlighting innovative cancer treatment developments.

Conferences

03/16/2026

Positive Trials for Belzutifan in Earlier Treatment Lines for RCC

Michael Serzan, MDToni Choueiri, MD
EV Plus Pembrolizumab and Systemic Therapy Advances in GU Oncology - OncUpdates.

Conferences

03/16/2026

Community Takeaways From ASCO GU 2026

Regina Barragan-Carrillo, MDRaji Shameem, MD
Advanced molecular testing and targeted therapies for prostate cancer research and treatment.

Conferences

03/16/2026

ASCO GU 2026: Experts Highlight Key Updates in Prostate Cancer

Brooke Kania, DOSindhuja Kadambi, MD, MS
Postoperative radiation and personalized therapy in GU cancers, featuring two smiling female doctors against a cityscape background.

Conferences

03/16/2026

A Personalized Approach to Treating GU Cancers

Sophia Kamran, MDNatalie Reizine, MD
HER2-Directed Strategies in Urothelial Cancer, featuring Dr. Miles Hsu and Dr. Brendan Guercio discussing innovative treatments for bladder cancer, with a cityscape background.

Conferences

03/15/2026

Novel HER2–Targeting Therapies in Urothelial Cancer

Miles Hsu, MDBrendan Guercio, MD
Radiotherapy strategies in metastatic clear cell renal cell carcinoma featuring Dr. Shreyas Kalantri and Dr. Michael Serzan with a cityscape background.

Conferences

03/15/2026

Radiotherapy Strategies in Metastatic Clear Cell Renal Cell Carcinoma

Michael Serzan, MDShreyas Kalantri, MD
Advanced medical professionals discussing Radium-223 Plus Enzalutamide in mCRPC with bone metastases in an urban hospital setting.

Conferences

03/14/2026

PEACE-3 OS Data Support Radium-223 Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Sindhuja Kadambi, MD, MSKarine Tawagi, MD
Researchers Brendan Guercio, MD, and Andrea Apolo, MD, discuss circulating tumor DNA for guiding muscle-invasive bladder cancer treatment, with a cityscape background.

Conferences

03/13/2026

Circulating Tumor DNA to Guide Treatment in Muscle-Invasive Bladder Cancer

Brendan Guercio, MDAndrea Apolo, MD
ASCO GU 2026 conference banner highlighting novel therapies transforming genitourinary oncology, featuring the Golden Gate Bridge in San Francisco.

Conferences

03/13/2026

ASCO GU 2026: Novel Therapies Transform Genitourinary Oncology

Manas Pustake, MD
Enhanced cancer treatment research featuring Dr. Nicholas Simon and Dr. Sumanta Pal discussing Cabozantinib and novel doublets in advanced renal cell carcinoma.

Conferences

03/12/2026

Cabozantinib and Novel Doublets in Advanced RCC

Nicholas Simon, MDSumanta Pal, MD, FASCO
Advanced medical professionals discussing metastatic renal cell carcinoma treatment strategies in a modern urban setting.

Conferences

03/12/2026

First-Line Treatment Strategies in Metastatic Renal Cell Carcinoma

Andre Kydd, MD, PhDNicholas Simon, MD
PARP inhibitor combination therapy in metastatic prostate cancer, featuring Jeffrey Zhong, MD, and Karan Jatwani, MD, with a cityscape background.

Conferences

03/11/2026

PARP Inhibitor Combination Therapy in Metastatic Prostate Cancer

Karan Jatwani, MDJeffrey Zhong, MD
EV Plus Pembro improves outcomes in muscle-invasive bladder cancer in KEYNOTE-B15/EV-304, featuring researchers Rohit Gosain, MD, and Rahul Gosain, MD, MBA, with a cityscape background.

Conferences

03/10/2026

Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes in Muscle-Invasive Bladder Cancer in KEYNOTE-B15/EV-304

Rahul Gosain, MD, MBARohit Gosain, MD
Efficacy of Enfortumab Vedotin and Pembrolizumab in muscle-invasive bladder cancer treatment, featuring experts Elias Chandran and Vishesh Khanna against a cityscape background.

Conferences

03/09/2026

Enfortumab Vedotin-Pembrolizumab’s Role in Muscle-Invasive Bladder Cancer Treatment

Elias Chandran, MBBS, FRACPVishesh Khanna, MD
Evolving treatment strategies in bladder cancer research presented by OncUpdates, featuring medical professionals discussing innovative therapies and recent advancements in bladder cancer management.

Conferences

03/09/2026

Insights from ASCO GU 2026: Evolving Treatment Strategies in Bladder Cancer

Zeynep Irem Ozay, MD
Enhanced immunotherapy plus BCG treatment for high-risk non-muscle invasive bladder cancer; two doctors in formal attire with cityscape background.

Conferences

03/08/2026

Immunotherapy Plus BCG Shows Promise in NMIBC: Insights From POTOMAC and CREST

Ashish M. Kamat, MD, MBBS, FACSVishesh Khanna, MD
Advanced prostate cancer treatment research featuring Karan Jatwani, MD, and Alan Bryce, MD, with a city skyline background.

Conferences

03/06/2026

Capivasertib Plus Abiraterone in Metastatic Prostate Cancer

Alan Bryce, MDKaran Jatwani, MD
Evolving standards in renal cell carcinoma research and treatment, with practical insights for healthcare professionals and oncologists.

Conferences

03/05/2026

Evolving Standards in Renal Cell Carcinoma: Practical Insights from ASCO GU

Adriana Penate, MD
Dr. Rebecca Shatsky discusses clinical trials on adjuvant carboplatin and PARP inhibitors in triple-negative breast cancer (TNBC) at OncUpdates.

Conferences

03/05/2026

Adjuvant Carboplatin and PARP Inhibitor Combination Trials in TNBC

Rebecca Shatsky, MDRahul Gosain, MD, MBARohit Gosain, MD
An image of Dr. Jorge Cortes presenting AML and CML highlights from ASH 2025, featuring Dr. Rahul Gosain and Dr. Rohit Gosain, with a professional background related to hematology and oncology researc.

Conferences

03/04/2026

AML and CML Highlights From ASH 2025

Jorge Cortes, MDRahul Gosain, MD, MBARohit Gosain, MD
Bispecifics, BTK inhibitors, and immunotherapy advances in lymphoma treatment, featuring experts Dr. Rahul Gosain, Dr. Julie Vose, and Dr. Rohit Gosain at OncUpdates conference.

Conferences

02/26/2026

Bispecifics, BTK Inhibitors, and Immunotherapy Drive Lymphoma Advances

Julie Vose, MD, MBARahul Gosain, MD, MBARohit Gosain, MD
A groundbreaking presentation on AQUILA, COBRA, TecLLE, and MajesTEC-3 trials highlighting innovative signal shifts in myeloma management by leading oncology experts.

Conferences

02/24/2026

AQUILA, COBRA, TecLILLE, and MajesTEC-3 Trials Signal Shifts in Myeloma Management

Ben Derman, MDRahul Gosain, MD, MBARohit Gosain, MD
Advanced visualization of immune cells and cancerous cells related to multiple myeloma, highlighting emerging treatment strategies and expert insights.

Conferences

02/19/2026

Expert Insight on Emerging Strategies in Multiple Myeloma

Mehndi Dandwani, MD
Advanced research on gastrointestinal cancers highlighting biomarker-driven therapies for CRC and NETs, featuring expert insights from Deepak Vadehra, DO, at Roswell Park Comprehensive Cancer Center.

Conferences

02/12/2026

Gastrointestinal Cancers: Biomarker-Driven Advances in CRC and NETs

Deepak Vadehra, DO
Dr. Harold Burstein presenting at SABCS 2025 on four key HER2+ breast cancer trials, with images of Dr. Rahul Gosain and Dr. Rohit Gosain in the background.

Conferences

02/10/2026

4 Significant Trials for HER2+ Breast Cancer at SABCS 2025

Harold Burstein, MD, PhDRohit Gosain, MDRahul Gosain, MD, MBA
Early morning view of a waterfront with a promotional banner for OncUpdates, featuring Dr. Hope Rugo and two other doctors discussing metastatic HR+ breast cancer highlights for SABCS 2025.

Conferences

02/06/2026

HR+ Metastatic Breast Cancer Updates from SABCS 2025

Hope Rugo, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
Improved, SEO-friendly responses:.

Conferences

02/05/2026

The Uncertain Role of ctDNA in Colorectal Cancers

Lauren Laderman, MDUdhayvir Singh Grewal, MD
Early-Onset Gastrointestinal Cancers research highlights genetics, survivorship, and care models for young patients, featuring MDs Youssef Bouferraa and Shruti Patel in an oncology conference setting.

Conferences

02/04/2026

Updating Care Models for Patients With Early-Onset GI Cancer

Youssef Bouferraa, MDShruti Patel, MD
1. Expert discussion on preventing chemotherapy toxicity and the importance of universal DPYD testing for cancer patients.

Conferences

02/03/2026

FDA Update Reflects Need for Genetic Testing Prior to Capecitabine

Karen MerrittVimal Scott Kapoor, MD, BSc, MSc
NGS and targeted therapies for advanced gastroesophageal cancer, featuring specialists Ajinkya Buradkar, MD and Meghana Singh, MD, with a cityscape background and professional medical presentation.

Conferences

01/29/2026

Biomarker Testing and Key Subgroups in Gastric and GEJ Cancer

Ajinkya Buradkar, MDMeghana Singh, MD
Metastatic neuroendocrine tumor research featuring scientists Udhayvir Grewal and Neena Vijayvergia with a city skyline and bridge background, highlighting innovative neuroendocrine tumor imaging tools.

Conferences

01/27/2026

64Cu-SARTATE Improves Tumor Detection in GEP-NETs

Udhayvir Singh Grewal, MDNeena Vijayvergia, MD
Zolbetuximab immunotherapy research on upper GI cancers with Dr. Shruti Patel and Dr. Timothy Brown on OncUpdates platform, highlighting innovative cancer treatment developments and future of targeted therapies.

Conferences

01/26/2026

The Future of Zolbetuximab in Upper GI Cancers

Timothy Brown, MD, MSCEShruti Patel, MD
PARP inhibition and immunotherapy in gastrointestinal malignancies, featuring experts Kriti Ahuja, MBBS, and Dr. Dina Ioffe, exploring biological rationale for advanced cancer treatment strategies.

Conferences

01/24/2026

ASCO GI 2026 Highlights: PARP Inhibitors Plus Immunotherapy

Kriti Ahuja, MDDina Ioffe, MD
CT22-01-2023 - Medical professional analyzing upper gastrointestinal cancer research updates at Roswell Park, highlighting practice-changing advances in diagnosis and treatment.

Conferences

01/23/2026

Practice-Changing Updates in Upper Gastrointestinal Cancers From ASCO GI 2026

Vaishali Deenadayalan, MD
HER2-targeted therapy in upper GI cancers, innovative strategies for treatment and research advancements by oncologists Meghana Singh and Richard Dunne.

Conferences

01/23/2026

HER2-Targeted Regimens Transform Frontline Management of Upper GI Cancers

Richard Dunne, MD, MSMeghana Singh, MD
1. OncUpdates logo with a San Francisco bridge and city skyline background, focusing on cancer research, oncology updates, and metastatic colorectal cancer strategies.

Conferences

01/22/2026

Expert Perspectives on the BREAKWATER Trial in Metastatic Colorectal Cancer

Daniel Tuerff, MDNicholas Hornstein, MD, PhD
1. Expert panelists Dr. Rohit Gosain, Dr. Rachna Shroff, and Dr. Rahul Gosain discuss key insights on gastrointestinal cancers at the 2026 ASCO Gastrointestinal Cancers Symposium.

Conferences

01/22/2026

4 Key Abstracts from the 2026 ASCO Gastrointestinal Cancers Symposium

Rachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
CBADet, MSS Colorectal Cancer, and Emerging Practice-Changing Data in Oncology research and updates.

Conferences

01/21/2026

CABINET and STELLAR-303 Trials Inform Treatment in NETs and mCRC

Nicholas Hornstein, MD, PhDAnwaar Saeed, MD
Pancreatic cancer biomarker testing and clinical decision-making, patient-centered care seminar featuring Fiyinfolu Balogun MD PhD and Wungki Park MD MS in front of a cityscape with a bridge at sunset.

Conferences

01/19/2026

ASCO GI 2026: Precision Medicine Gains Momentum in Pancreatic Cancer

Fiyinfolu Balogun, MD, PhDWungki Park, MD, MS
KRAS inhibitors, targeted therapy, GI oncology, cancer treatment, molecular targeted therapy, cancer research, precision medicine, oncology advancements, clinical oncology, cancer therapy innovation.

Conferences

01/19/2026

Molecular Profiling Expands Treatment Options in Pancreatic and Biliary Tract Cancers

Dina Ioffe, MDShubham Pant, MD, MBBS
1. Hands holding a pink ribbon symbolizing breast cancer awareness on a gray background.

Conferences

01/17/2026

From ADCs to Oral SERDs: Practice-Changing Insights from SABCS 2025

Zunairah Shah, MD
1. Expert doctors Mariam Haji Ahmad and Alexis Levee discuss early use of first-line ADCs in breast cancer treatment and advancements in sequencing technology for improved patient outcomes.

Conferences

01/17/2026

Impact of  ADCs in Early TNBC Treatment

Mariam Haji Ahmad, MBBChAlexis Levee, MD
Azacitidine and venetoclax combination therapy for AML, showcasing practice-changing insights from ASH 2025 presented by Jayastu Senapati and Uma Borate.

Conferences

01/16/2026

Azacitidine in AML: Key Takeaways From the PARADIGM Study

Jayastu Senapati, MBBSUma Borate, MBBS
Multimodal image featuring two doctors discussing cellular therapy for multiple myeloma, with cityscape background, emphasizing oncology research, CAR T-cell therapy, bispecific antibodies, and personalized cancer care advancements.

Conferences

01/16/2026

Collaboration is Key to Safely Transition Care in MM Following Cellular Therapy

Hamza Hashmi, MDShreyas Kalantri, MD
1. OncUpdates logo with two doctors discussing Hodgkin lymphoma data and treatment advancements for improved patient outcomes.

Conferences

01/15/2026

Insights on CAR-NK Therapy and Hodgkin Lymphoma Updates at ASH 2025

Sam Yamshon, MDAndrew Evens, DO, MBA, MSc
Antibody-drug conjugates reshaping triple-negative breast cancer treatment algorithm, oncologists discuss advances.

Conferences

01/15/2026

ADCs in TNBC: Current Data and Unanswered Questions

Pietro De Placido, MDDionisia Quiroga, DO, PhD
Inovative breast cancer research and treatment insights from OncUpdates, featuring experts Tyler Kristoff, MD, and Sarah Premji, MD, focusing on the role of Inavolisib as a first-line therapy and emerging oral SERDs.

Conferences

01/13/2026

SABCS 2025 Updates on Inavolisib and Giredestrant in Breast Cancer

Tyler Kristoff, MDSarah Premji, MD
1. Expert oncologists Kingsley Nnawuba and Urshila Durani discuss advancements in lymphoma treatment, including ESMO guidelines, immunotherapy, and combination therapies for improved patient outcomes.

Conferences

01/13/2026

Oncologists Review Practice-Changing Lymphoma Findings From ASH 2025

Kingsley Nnawuba, MDUrshila Durani, MD, MPH
1. In-depth analysis of HR+ and early breast cancer studies from SABCS 2025 featuring experts Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Laura Huppert.

Conferences

01/12/2026

Key HR+, Early Breast Cancer Abstracts From SABCS 2025

Laura Huppert, MDRahul Gosain, MD, MBARohit Gosain, MD
Blood sample in a test tube with laboratory report background, highlighting hematology and oncology research.

Conferences

01/11/2026

Key Studies Shaping Hematology, Community Oncology at ASH 2025

Sawyer Bawek, DO
Prognostic criteria and role of Daratumumab in high-risk smoldering myeloma, featuring experts Jing Wang, MD and Anuja Abhyankar, MD, discussing recent advancements in multiple myeloma treatment.

Conferences

01/08/2026

Early Intervention Strategies in High-Risk Smoldering Multiple Myeloma

Anuja V. Abhyankar, MDJing Wang, MD
Enhanced medical research on hematology and oncology at ASH 2025 conference with clinical laboratory professionals.

Conferences

01/07/2026

ASH 2025 Breakthroughs: Key Studies Shaping Hematology and Community Oncology

Sawyer Bawek, DO
HER2-positive breast cancer research update featuring Yash Agrawal, MD, and Stephanie Graff, MD, discussing 2025 advancements in DESTINY trials and beyond for improved breast cancer therapies.

Conferences

01/05/2026

The Evolving Role of T-DXd Across HER2+ Breast Cancer

Yash Agrawal, MDStephanie Graff, MD, FACP, FASCO
1. Female healthcare professionals discussing breast cancer prevention and patient advocacy for cancer care education and empowerment.

Conferences

01/04/2026

Patient Advocacy Brings Breast Cancer Vaccine to Phase 1 Trial

Judy FitzgeraldKarissa Britten, MD
1. Researchers and clinicians discuss strategies for managing lenalidomide, CD38, and multi-refractory disease in relapsed multiple myeloma treatment at OncUpdates conference.

Conferences

01/04/2026

How to Select Treatment in Relapsed Multiple Myeloma

Anuja V. Abhyankar, MDS. Vincent Rajkumar, MD
Early use of bispecific antibodies and CAR T strategies in relapsed multiple myeloma, discussed by experts Hamza Hashmi, MD, and Robert Orlowski, MD, PhD, with a cityscape background.

Conferences

01/03/2026

Bispecific Antibodies and CAR T Redefine Early-Line Treatment in Multiple Myeloma

Robert Orlowski, MD, PhDHamza Hashmi, MD
Enhanced image of two medical professionals discussing CDK4/6 inhibitors for cancer treatment at OncUpdates, with a cityscape background highlighting expertise in oncology research and therapy options.

Conferences

01/02/2026

NATALEE 5-Year IDFS Data at SABCS 2025

Matthew Kurian, MDJasmin Hundal, MD
1. Expert discussion on TROP2 ADC options in PD-L1-negative TNBC featuring Alexis LeVee and Paolo Tarantino, MD.

Conferences

01/01/2026

Anti-TROP-2 ADCs in PD-L1-Negative TNBC

Alexis Levee, MDPaolo Tarantino, MD
Advanced AML treatment discussing FLT3 inhibitors, menin targeting, and triplet regimens with experts Abhishek Maiti, MD, and Jorge Cortes, MD, in a clinical oncology-focused presentation.

Conferences

01/01/2026

Targeted Combinations Transform AML Care

Abhishek Maiti, MDJorge Cortes, MD
1. Expert oncologists discussing future trends in chronic myeloid leukemia (CML) therapy and insights from key clinical trials including ASC4, OPTIC, and ASXL1 for 2025.

Conferences

12/31/2025

ASH 2025 CML Highlights: Asciminib, Ponatinib Optimization, and Treatment Sequencing

Sawyer Bawek, DOFadi Haddad, MD
1. Advanced biomarker-guided care in HER2-positive breast cancer using ctDNA, TILs, and HER2DX for personalized oncology treatment and improved patient outcomes.

Conferences

12/31/2025

Emerging Roles of Biomarkers in HER2-Positive Breast Cancer 

Yash Agrawal, MDMadison Canning, MD
HER2-positive breast cancer updates from SABCS 2023, featuring expert Vaishali Deenadayalan at Roswell Park, emphasizing advancements in treatment and research in oncology for improved patient outcomes.

Conferences

12/30/2025

Updates in HER2-Positive Breast Cancer From SABCS 2025

Vaishali Deenadayalan, MD
Pre-transplant functional status as a predictor of autologous myeloma transplant outcomes, featuring Rahul Gosain, MD, MBA and Sawyer Bawek, DO, with a cityscape background.

Conferences

12/29/2025

Pretransplant Functional Status as a Predictor of Outcomes in Multiple Myeloma

Sawyer Bawek, DORahul Gosain, MD, MBA
1. Interpreting MONALEESA, NATALEE, and monarchE in clinical oncology practice, featuring healthcare professionals discussing advanced breast cancer treatments.

Conferences

12/29/2025

SABCS 2025: Expert Perspective on CDK4/6 Inhibitor Use in Metastatic Hormone Receptor-Positive Breast Cancer

Matthew Kurian, MDElia Segui Solis, MD
1. Advanced breast cancer treatment strategies for early HER2-positive cases, featuring expert insights from MDs Ya Haddy Salah and Nerea Lopetegui.

Conferences

12/28/2025

De-escalation and Sequencing Strategies Shape HER2-Positive Breast Cancer Care at SABCS 2025

Nerea Lopetegui-Lia, MDYa Haddy Sallah, MD, MPH
Innovative hormone receptor-positive breast cancer treatment paradigms discussed by Dr. Jasmin Hundal, expert from Cleveland Clinic, highlighting advancements and research updates in oncology.

Conferences

12/27/2025

Shifting Treatment Paradigms in Hormone Receptor–Positive Breast Cancer 

Jasmin Hundal, MD
1. Integrating Tucatinib and T-DXd for HER2-positive breast cancer treatment, across disease settings, to enhance targeted therapy effectiveness and patient outcomes.

Conferences

12/26/2025

SABCS 2025: HER2CLIMB-05 and DESTINY Trials Point to More Individualized Care in HER2-Positive Breast Cancer

Nerea Lopetegui-Lia, MDSusan Dent, BSc, MD
Accelerating breast cancer treatment research by integrating Sacituzumab govitecan, Pembrolizumab, with expert clinicians Dionisia Quiroga, DO, PhD, and Erika Hamilton, MD, in Las Vegas skyline background.

Conferences

12/25/2025

SABCS 2025: Clarifying Where Sacituzumab Govitecan Fits in the Breast Cancer Treatment Landscape

Erika Hamilton, MD, FASCODionisia Quiroga, DO, PhD
Bispecific antibodies and CAR T-cell therapy for emerging data in TP53-mutated AML and MDS, featuring experts Mycal Casey, DO, and Abishek Maiti, MD, at OncUpdates conference.

Conferences

12/24/2025

Reviewing ASH 2025 Data for ALL and TP53-Mutated AML or MDS

Abhishek Maiti, MDMycal Casey, DO
1. Advanced blood cancer cells including leukemia, lymphoma, myeloma, and chronic lymphocytic leukemia (CLL).

Conferences

12/24/2025

CLL, AML, Lymphoma, and Myeloma Updates Poised to Impact Clinical Practice

Valentina Ardila Avila, MD
1. Expert oncologists discussing treatment options for cancer, emphasizing Venetoclax-based regimens, targeted agents, and rapid molecular profiling for personalized therapy.

Conferences

12/23/2025

Improving Venetoclax and Other Targeted Therapies in AML

Zachary Braunstein, MDJayastu Senapati, MBBS
Enhanced leukemia research and advancements discussed at ASH 2025, offering expert insights and future directions in hematologic cancer treatment from renowned specialists.

Conferences

12/23/2025

Leukemia Advances at ASH 2025: Expert Insights and Future Directions

Niranjan Khaire, MBBS, MD, DM
Advanced personalized chemotherapy strategies for chronic lymphocytic leukemia based on ASH 2025 guidelines. Expert insights by Lauren M. Granat, DO, MS, on targeted cancer therapies.

Conferences

12/22/2025

ASH 2025 Signals Shift Toward Personalized, Time-Limited Therapy in Chronic Lymphocytic Leukemia

Lauren M. Granat, DO, MS
Adjuvant CDK4/6 inhibition in early breast cancer discussed by renowned experts Matthew Kurian and Komal Jhaveri at OncUpdates.

Conferences

12/21/2025

NATALEE and Other Updates for HR+ Early Breast Cancer at SABCS 2025

Komal Jhaveri, MD, FACPMatthew Kurian, MD
1. Experienced medical professionals discussing Sonrotoclax in mantle cell lymphoma at ASH 2025 clinical conference.

Conferences

12/20/2025

Experts Discuss Sonrotoclax and Lymphoma Trials at ASH 2025

Agrima Mian, MDSam Yamshon, MD
1. OncUpdates logo with a background of a city skyline and water, focused on hematology and oncology treatment updates.

Conferences

12/20/2025

Ibrutinib Updates in CLL From ASH 2025

Mahesh Swaminathan, MB, MSVanthana Bharthi, MD
1. OncUpdates logo with medical professionals discussing novel therapies for HER2-positive and triple-negative breast cancer.

Conferences

12/19/2025

Evolving Treatment Paradigms in Advanced Breast Cancer: Key Trial Updates From SABCS 2025

Karissa Britten, MDVaishali Deenadayalan, MD
1. Advances in early-stage breast cancer treatment focusing on CDK4/6 inhibitors for adjuvant therapy.

Conferences

12/19/2025

Key Insights From the NATALEE Trial 

Karissa Britten, MDMatthew Kurian, MD
Advances in early-stage and metastatic triple-negative breast cancer (TNBC) treatments, featuring expert insights from Dr. Briana To, highlighting evolving oncologic approaches and clinical research.

Conferences

12/19/2025

Evolving Approaches to Early-Stage and Metastatic TNBC

Briana To, DO, PhD
1. AlT text: Expert discussion on managing breast cancer relapse with adjuvant CDK4/6 inhibitor therapy in ER-positive cases, featuring Dr. Sarah Premji and Dr. Kevin Kalinsky.

Conferences

12/18/2025

SABCS 2025: Evolving Role of CDK4/6 Inhibitors and SERDs in ER-Positive Breast Cancer

Kevin Kalinsky, MD, MS, FASCOSarah Premji, MD
1. Expert insights on frontline BTK inhibitors and triplet therapy for CLL at ASH 2025, featuring Mahesh Swaminathan and Bita Fakhri.

Conferences

12/18/2025

Breaking Down ASH 2025 Data on Frontline Pirtobrutinib in CLL

Bita Fakhri, MD, MPHMahesh Swaminathan, MB, MS
Non-covalent BTKi efficacy post-covalent BTKi or BCL-2 therapies in cancer treatment, featuring experts Claudia Villa Celi, MD, and Daniel Ermann, MD, for oncology research updates.

Conferences

12/18/2025

Sequencing BTKi Therapies in Patients With CLL

Claudia Villa Celi, MDDaniel Ermann, MD
1. Two healthcare professionals, a male and female doctor, smiling against a city skyline at dusk, promoting oncology research updates on BTK inhibitors and therapy in CLL.

Conferences

12/17/2025

SEQUOIA Trial Long-Term Data Support Second-Generation BTK Inhibitors in CLL

Catherine Coombs, MDDaniel Ermann, MD
Imaging for oncological research on follicular lymphoma, featuring MDs Urshila Durani and Joshua Brody, highlighting practice-changing data from EPCORE FL-1 clinical trial in a skyline cityscape background.

Conferences

12/17/2025

Primary Results From EPCORE FL-1 Presented at ASH 2025

Urshila Durani, MD, MPHJoshua Brody, MD
1. New research data on lymphoma care presented at ASH 2025, emphasizing advances from frontline treatment to relapse management.

Conferences

12/14/2025

New Data at ASH 2025 Reshapes Lymphoma Care From Frontline to Relapsed Disease

Rafaella Litvin, MD
1. Medical professional analyzing lung cancer CT scan highlighting tumor with red laser pointer, illustrating cancer diagnosis and screening.

Conferences

11/25/2025

Revolutionizing Treatment for EGFR-Mutated NSCLC

Coral Olazagasti, MD
Malignant tumor in the lung with cancerous growth and tumor cells, medical illustration of lung cancer pathology for oncology and cancer research.

Conferences

11/17/2025

Dual Targeting: Iza-bren Shows Promising Early Results Across Solid Tumors

Samantha El Warrak, MBBSChinmay Jani, MD
Lung cancer with tumor showing cancerous growth affecting the bronchi and surrounding lung tissue, emphasizing medical research and oncology treatment.

Conferences

11/14/2025

PALOMA-2: Subcutaneous Amivantamab Plus Lazertinib Delivers MARIPOSA-Level Efficacy with Improved Safety

Akshee Batra, MDChinmay Jani, MD
Innovative targeted antibody-drug conjugate for relapsed small cell lung cancer (SCLC) at WCLC 2025. Focus on recent developments in cancer immunotherapy and targeted treatments for lung cancer patients.

Conferences

11/13/2025

DLL3-Targeted Antibody-Drug Conjugate Reignites Hope for Relapsed SCLC

Asad Rauf, MDChinmay Jani, MDAman Chauhan, MD
CT scan of a chest showing lung health, used in cancer diagnosis and treatment monitoring.

Conferences

11/12/2025

Chemotherapy Plus Osimertinib Offers Overall Survival Benefit in EGFR-mutated NSCLC

Daniel Tuerff, MDChinmay Jani, MDEstelamari Rodriguez, MD, MPH
ESMO 2025 conference banner highlighting updates in HR+ metastatic breast cancer landscape, with a historic building in the background.

Conferences

11/10/2025

ESMO 2025: Updates in the HR+ Metastatic Breast Cancer Landscape 

Sarah Premji, MDKarthik Giridhar, MD
Advanced medical professionals discussing lung cancer updates at ESMO 2025 conference, emphasizing recent oncological research and treatment innovations for thoracic oncology.

Conferences

11/07/2025

5 Updates From ESMO 2025 for Lung Cancer Oncologists

Rami Manochakian, MDRohit Gosain, MDRahul Gosain, MD, MBA
PSA test blood sample for prostate cancer detection in laboratory setting.

Conferences

11/06/2025

ESMO 2025 Updates in Prostate Cancer: Advances in Radioligand, Genomic, and AR-Targeted Therapies

Michael Serzan, MD
ESMO 2025: SERDs, mTOR inhibitors, and VIKTORIA-1 targeted therapies for advanced breast cancer research and treatment advancements.

Conferences

11/05/2025

Metastatic Breast Cancer Updates: SERDs, mTOR Inhibitors, and VIKTORIA-1

Erika Hamilton, MD, FASCOSarah Premji, MD
Advanced medical conference featuring Dr. Rachna Shroff, Dr. Rohit Gosain, and Dr. Rahul Gosain discussing key updates on gastrointestinal cancer from ESMO 2025 in a professional setting.

Conferences

11/04/2025

5 Key GI Cancer Updates From ESMO 2025

Rachna Shroff, MD, MS, FASCORohit Gosain, MDRahul Gosain, MD, MBA
8 Practice-Changing Breast Cancer Presentations From ESMO 2025 with leading doctors Dr. Rahul Gosain, Dr. Rohit Gosain, and Dr. Virginia Kaklamani; innovative updates in breast cancer diagnosis, treatment, and care discussed at OncUpdates.

Conferences

11/03/2025

8 Practice-Changing Breast Cancer Presentations From ESMO 2025

Virginia Kaklamani, MD, DScRahul Gosain, MD, MBARohit Gosain, MD
Updated Results from monarchE Presented at ESMO 2025, featuring Erika Hamilton, MD, FASCO, and Sarah Premji, MD, discussing recent oncology advancements.

Conferences

10/31/2025

Dr. Erika Hamilton on Updated Results From monarchE Presented at ESMO 2025

Erika Hamilton, MD, FASCOSarah Premji, MD
Advanced oncology conference presentation featuring Dr. Rahul Gosain, Dr. Rohit Gosain, and Dr. Stephanie Berg discussing top GU oncology topics from ESMO Congress 2025.

Conferences

10/30/2025

Top 5 GU Oncology Presentations From ESMO Congress 2025

Stephanie Berg, DORahul Gosain, MD, MBARohit Gosain, MD
Berlin Museum Island with historical architecture and river view during sunset, featuring a boat cruising on the Spree River, with modern Berlin skyline in the background.

Conferences

10/29/2025

ESMO 2025: Updates in Bladder Cancer

Vishesh Khanna, MD
Electronic health records consultation with healthcare professional discussing cancer treatment options.

Conferences

10/28/2025

ESMO 2025 Breaking New Ground in Breast Cancer: Five Trials to Know

Matthew Kurian, MD
Vibrant scientific laboratory scene with test tubes and a pipette, showcasing advanced cancer research and clinical trials, highlighting oncology innovations and medical breakthroughs in cancer treatment.

Conferences

10/25/2025

ESMO 2025: Updated Results From the monarchE Trial in Early Breast Cancer

Sarah Premji, MDMatthew Goetz, MD
Microscopic view of cancer cells, illustrating cellular structures and tumor development for oncology research and cancer treatment insights.

Conferences

10/24/2025

Key Updates in Gastrointestinal Oncology from ESMO 2025

Udhayvir Singh Grewal, MD
Berlin cityscape at dusk with the TV Tower, historic buildings, and river, highlighting oncology research and medical innovation in Germany for oncology updates and cancer treatment advancements.

Conferences

10/17/2025

The 12 Most Anticipated Practice-Changing Abstracts at ESMO 2025: Community Oncologist’s Guide

Sawyer Bawek, DO
WCLC 2025 oncology conference highlights featuring key researchers discussing FLURA2, HARMONI, and ALCHEMIST targeted therapies for lung cancer treatment.

Conferences

10/08/2025

Key NSCLC Trials From WCLC 2025 

Balazs Halmos, MDRahul Gosain, MD, MBARohit Gosain, MD
Innovative cancer research expert speaking at OncUpdates conference, discussing latest advancements in oncology and personalized treatment strategies, in a professional setting.

Conferences

09/09/2025

Preferred Sequencing of Treatment for Neuroendocrine Tumors

Deepak Vadehra, DOTanios Bekaii-Saab, MD
Microscopic view of cancer cells with surrounding blood cells and immune response, illustrating recent oncological updates and advancements in cancer research.

Conferences

08/26/2025

Updates in Breast Cancer From ASCO 2025

Zunairah Shah, MD
Lung anatomy with highlighted bronchi and surrounding structures in a digital medical illustration.

Conferences

07/28/2025

Thoracic Oncology in 2025: Evolving Standards and Practice-Changing Data From ASCO

Kriti Ahuja, MD
A woman speaking at an oncology conference, wearing a black leather jacket and a red heart-shaped brooch, with a backdrop displaying "Advancements in Oncology" and "Onc Brothers.".

Conferences

07/25/2025

Innovación dirigida: datopotamab deruxtecan en el tratamiento del cáncer de pulmón no microcítico avanzado

Coral Olazagasti, MDNarjust Florez, MD, FASCO
OncUpdates breast cancer clinical trials expert panel discussing key advancements in breast cancer treatment and innovative therapies. Featuring Dr. Erika Hamilton, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Conferences

07/22/2025

5 Key Breast Cancer Clinical Trials Shaping Treatment

Erika Hamilton, MD, FASCOSarah Cannon Research Institute
GU Malignancy Recap from 2025 ASCO, oncology, cancer research, medical conference, Dr. Tian Zhang, Dr. Rohit Gosain, Dr. Rahul Gosain, oncotherapy, cancer treatment advances, oncology news, clinical updates, oncologists, cancer management.

Conferences

07/22/2025

GU Malignancy Recap from 2025 ASCO

Tian Zhang, MD, MHS
Healthcare professional giving a presentation at an oncology conference, promoting advancements in cancer research and treatment, with a focus on future practices and innovative oncology breakthroughs.

Conferences

07/02/2025

Datopotamab Deruxtecan in NSCLC: A Closer Look at TROP2-Targeted Therapy

Coral Olazagasti, MDNarjust Florez, MD, FASCO
OncUpdates conference panel discussion featuring medical professionals discussing oncology advancements and cancer treatment strategies at a professional medical event.

Conferences

07/02/2025

Breakthroughs in Bladder, Prostate, and Kidney Cancer: What Oncologists Need to Know From ASCO 2025

Saad Atiq, MD
Microcancer cells in human bladder illustrating cancer biology and urology research.

Conferences

06/30/2025

Durvalumab Enters the Perioperative Landscape in Muscle-Invasive Bladder Cancer: Reflections from the NIAGARA Trial and ASCO 2025 Updates

Charbel Matar, MD
Five major colorectal and gastrointestinal cancer abstracts from 2025 ASCO conference, analyzed by oncologists with insights on latest research and breakthroughs in cancer treatment.

Conferences

06/27/2025

Five Major Colorectal and GI Cancer Abstracts From 2025 ASCO

Rahul Gosain, MD, MBARohit Gosain, MDCathy Eng, MD, FACP, FASCO
Innovative cancer research discussion at OncUpdates featuring leading oncologists sharing insights on recent advances in oncology treatments and therapies.

Conferences

06/11/2025

Clinical Impact of DESTINY-Breast09 in HER2+ Breast Cancer Management

Arya Mariam Roy, MDHope Rugo, MD, FASCO
Innovative oncology conference with experts discussing advancements in cancer treatment and research in a modern, well-lit venue.

Conferences

06/11/2025

Small Cell Lung Cancer Takes Center Stage at ASCO 2025

Eric Singhi, MDSandip Patel, MD, FASCO
Advances in oncology, cancer research, and breakthrough treatments discussed at an oncology conference with medical professionals.

Conferences

06/11/2025

Strategic Timing for Multidisciplinary Care in Breast Cancer

Jasmin Hundal, MDMatthew Kurian, MD
Innovative oncology discussion at OncUpdates conference focused on advancements in cancer treatment and care. Two experts sharing insights on future oncology practices at the event.

Conferences

06/11/2025

ASCO 2025: Key Clinical Trials in Resectable NSCLC

Eric Singhi, MDMitchell Alexander Parma, MD
Oncoupdates, oncology conference, medical professionals, cancer research, healthcare presentation, cancer awareness, medical event, oncology advancements, professional networking, cancer treatment innovation.

Conferences

06/11/2025

Tailoring Treatment for Patients With EGFR-Positive NSCLC

Chinmay Jani, MDCoral Olazagasti, MD
High-tech illustration of a human prostate gland with medical visualization elements, symbolizing advanced prostate cancer research and treatment options.

Conferences

06/11/2025

New Questions in Muscle-Invasive Bladder Cancer After the NIAGARA Trial

Albert Jang, MDMichael Serzan, MD
Advances in oncology research and treatment discussed at OncUpdates, featuring medical professionals sharing insights on cancer therapies and breakthroughs, highlighting the latest in cancer care.

Conferences

06/11/2025

Highlights From the AMPLITUDE Study at ASCO 2025

Albert Jang, MDMichael Serzan, MD
Alcohol-reinforcement-removal-urinary-kidney-cancer-treatment-therapy-illustration.

Conferences

06/11/2025

Updated CheckMate 214 Results Support Ipi-Nivo for Favorable-Risk Kidney Cancer

Albert Jang, MDMichael Serzan, MD
Data for tomorrow’s oncology practice and research, oncological innovations, cancer treatment advancements, and cancer research updates at OncUpdates.

Conferences

06/11/2025

MATTERHORN Trial: Promising Results and Unanswered Questions

Deepak Vadehra, DOSupriya Peshin, MD
Innovative oncology research discussion at OncUpdates conference, focusing on advancements in cancer treatment, personalized medicine, and new therapies in oncology.

Conferences

06/11/2025

Diverse Bispecific Strategies Emerging Across GI Cancers

Shruti Patel, MDUdhayvir Singh Grewal, MD

Conferences

06/11/2025

Advancements in Oncology at ASCO 2025: Breast Cancer Highlights

Tanmayi Pai, MD
High-quality healthcare professional woman speaking at oncology conference, discussing cancer treatment updates, in a comfortable, modern setting with natural lighting and stylish decor.

Conferences

06/10/2025

Key Takeaways From ASCO 2025 for Hormone-Receptor+ Metastatic Breast Cancer

Komal Jhaveri, MD, FACPMatthew Kurian, MD
Leading female medical expert speaking at a conference on oncology advances, holding a microphone, surrounded by large green plants, emphasizing innovative cancer research and treatment updates.

Conferences

06/10/2025

Integrating Metastatic Triple-Negative Breast Cancer NCCN Guidelines Into Clinical Practice

Arya Mariam Roy, MDHope Rugo, MD, FASCO
Senior woman and young woman with microphones at a cancer research conference or interview, standing in front of a green hedge with a banner displaying "Today's Data for Tomorrow's Practice" and "OncUpdates" logo.

Conferences

06/10/2025

ASCENT-04 Trial: First-Line Sacituzumab Govitecan Plus Pembrolizumab Improves PFS in PD-L1+ TNBC

Arya Mariam Roy, MDHope Rugo, MD, FASCO
Innovative oncology conference speakers discussing advancements in cancer research at OncUpdates event.

Conferences

06/10/2025

Lurbinectedin Offers Significant Survival Benefit for Patients With Extensive-Stage SCLC

Eric Singhi, MDSandip Patel, MD, FASCO
Bald man in suit and tie speaking into a microphone at a conference, sitting on a wicker armchair surrounded by plants and modern decor, representing oncology professional at a medical event.

Conferences

06/10/2025

Second-Line Treatment Sequencing in Metastatic RCC

Enrique Grande, MD, PhD, MSCKaran Jatwani, MD
Answer:.

Conferences

06/10/2025

NIAGARA Trial: A New Standard of Care in MIBC

Petros Grivas, MD, PhDMichael Serzan, MD
Cutting-edge oncology conference interview with medical professionals discussing advancements in cancer research and treatment strategies for improved patient outcomes.

Conferences

06/10/2025

The Future of Sacituzumab Govitecan in Metastatic Urothelial Cancer

Michael Serzan, MDPetros Grivas, MD, PhD
Innovative cancer treatment discussion at Oncology conference focusing on advancements in oncology research, therapies, and patient care.

Conferences

06/10/2025

Interpreting the Broad Cabozantinib Label for NETs

Neena Vijayvergia, MDShruti Patel, MD
Expert woman in black blazer speaking at a medical conference, discussing oncology topics and cancer research on stage.

Conferences

06/10/2025

Considering Frontline PRRT in NETs

Neena Vijayvergia, MDShruti Patel, MD
Discussion panel at a medical conference with professionals in a modern cityscape setting, focused on oncology updates and research advancements.

Conferences

06/10/2025

Shifting Paradigms in Lung Cancer Care: Insights From ASCO 2025

Maria A. Velez, MD, MS
Expert medical professionals discuss cancer treatment advances at an oncology conference, emphasizing personalized medicine and innovative research in cancer care.

Conferences

06/10/2025

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

Seyi Abidoye, MBBSLisa Liu, MD
Enhanced visualization of the human digestive system highlighting the stomach and intestines for medical and anatomical research.

Conferences

06/03/2025

ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE

Sawyer Bawek, DO
Innovative medical conference with healthcare professionals discussing oncology treatments and latest cancer research advancements in a modern venue.

Conferences

05/23/2025

Advances in Managing CNS Metastases in Breast Cancer: SABCS 2024 Insights

Hetal Mistry, MD

Clinical Insights

View All
Group of five leukemia specialists discussing FLT3 inhibitors in AML treatment, featuring Dr. Nicholas Short, Dr. Uma Borate, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Naval Dayer.

Clinical Insights

07/13/2026

Leukemia Specialists Review the Role of FLT3 Inhibitors Across AML Treatment Settings

Uma Borate, MBBSNaval Daver, MDNicholas Short, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel discussion on partnerships and outpatient strategies for bispecifics in multiple myeloma with Dr. S. Vincent Rajkumar, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Beth Faiman, and Dr. Rafael Fonseca.

Clinical Insights

07/10/2026

Ep 4. Community Perspective: Partnerships and Outpatient Strategies for Bispecifics in Multiple Myeloma 

Rohit Gosain, MDRahul Gosain, MD, MBAS. Vincent Rajkumar, MDRafael Fonseca, MDBeth Faiman, CNP, PhD
OncUpdates episode 3 features Dr. S. Vincent Rajkumar discussing managing side effects of BCMA bispecifics and Talquetamab in myeloma treatment.

Clinical Insights

07/09/2026

Ep 3. Managing Side Effects BCMA Bispecifics and Talquetamab in Myeloma

Rohit Gosain, MDRahul Gosain, MD, MBAS. Vincent Rajkumar, MDRafael Fonseca, MDBeth Faiman, CNP, PhD
OncUpdates Episode 2 features Dr. S. Vincent Rajkumar discussing bispecifics: MajesTEC-3, MajesTEC-9, and MonumenTAL-3 with expert panel.

Clinical Insights

07/08/2026

Ep 2. The Advent of Bispecifics: MajesTEC-3, MajesTEC-9, and MonumenTAL-3

Rohit Gosain, MDRahul Gosain, MD, MBAS. Vincent Rajkumar, MDRafael Fonseca, MDBeth Faiman, CNP, PhD
Dr. S. Vincent Rajkumar and colleagues discuss a new algorithm for second-line treatment of multiple myeloma in a medical webinar.

Clinical Insights

07/07/2026

Ep 1. The New Algorithm for Second-Line Treatment of Multiple Myeloma

Rohit Gosain, MDRahul Gosain, MD, MBAS. Vincent Rajkumar, MDRafael Fonseca, MDBeth Faiman, CNP, PhD
CAR T-cell therapy in multiple myeloma with insights from ASCO 2026, featuring experts Dr. Binod Dhakal, Dr. Surbhi Sidana, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Ajai Chari.

Clinical Insights

06/27/2026

CAR T in Myeloma: Earlier Use and Sequencing Insights from ASCO 2026

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Group of medical professionals discussing evolving treatment landscape in second-line and beyond multiple myeloma, with cityscape background.

Clinical Insights

06/26/2026

Evolving Treatment Landscape in Second-Line and Beyond Multiple Myeloma

Beth Faiman, CNP, PhDRafael Fonseca, MDS. Vincent Rajkumar, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of four medical experts discussing managing side effects of Luspatercept in a professional setting.

Clinical Insights

06/25/2026

Managing Side Effects of Luspatercept

Christopher Benton, MDJamile M. Shammo, MDTiffany Tanaka, MDAmer Zeidan, MBBS, MDRohit Gosain, MD
Image featuring Dr. Jamile M. Shammo, Dr. Tiffany Tanaka, Dr. Rohit Gosain, Dr. Amer Zeidan, and Dr. Christopher Benton discussing low-risk MDS and clinical trial data.

Clinical Insights

06/24/2026

Luspatercept: Clinical Trial Data and Lessons for Low-Risk MDS

Christopher Benton, MDJamile M. Shammo, MDTiffany Tanaka, MDAmer Zeidan, MBBS, MDRohit Gosain, MD
Panel of four medical experts discussing recent advancements in defining, diagnosing, and staging myelodysplastic syndromes (MDS) for oncology updates.

Clinical Insights

06/23/2026

Recent Advancements in Defining, Diagnosing, and Staging MDS

Christopher Benton, MDJamile M. Shammo, MDTiffany Tanaka, MDAmer Zeidan, MBBS, MDRohit Gosain, MD
Panel discussion on toxicity, patient selection, and future of Ivonescimab with Dr. Bo Wang, Dr. Benjamin P. Levy, and Dr. Jarushka Naidoo.

Clinical Insights

06/23/2026

Balancing Efficacy and Safety: Toxicity, Patient Selection, and the Future of Ivonescimab

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Panel of four hematology experts discussing Luspatercept and low-risk MDS treatment strategies in a medical webinar.

Clinical Insights

06/22/2026

Treating Low-Risk MDS After the Introduction of Luspatercept 

Christopher Benton, MDJamile M. Shammo, MDTiffany Tanaka, MDAmer Zeidan, MBBS, MDRohit Gosain, MD
Diverse group of medical professionals discussing gender representation and applicability of HARMONi-6 findings in oncology research.

Clinical Insights

06/22/2026

Gender Representation and Global Applicability of the HARMONi-6 Findings

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Image from OncUpdates showing Dr. Bo Wang, Dr. Benjamin P. Levy, and Dr. Jarushka Naidoo discussing age-related findings from the HARMONi-6 trial.

Clinical Insights

06/21/2026

Age-Related Findings and Subgroup Analyses From the HARMONi-6 Trial

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Image from OncUpdates showing Dr. Bo Wang, Dr. Benjamin P. Levy, and Dr. Jarushka Naidoo discussing HARMONi-6 trial results.

Clinical Insights

06/20/2026

Follow-Up Duration and Survival Trends in the HARMONi-6 Trial

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Group photo of three doctors discussing HARMONi-6 as a new option for squamous NSCLC in a clinical setting.

Clinical Insights

06/19/2026

HARMONi-6 Generates Enthusiasm as a Potential New Option for Squamous NSCLC

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Image showing Dr. Bo Wang, Dr. Benjamin P. Levy, and Dr. Jarushka Naidoo discussing dual PD-1/VEGF blockade in squamous lung cancer research.

Clinical Insights

06/18/2026

Clinical Insights: The HARMONi-6 Trial and Dual PD-1/VEGF Blockade in Squamous Lung Cancer

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Panel discussion on managing toxicity and expanding RAS therapy in pancreatic cancer featuring Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, and Dr. Shu.

Clinical Insights

06/16/2026

Managing Toxicity and Expanding RAS Therapy in Pancreatic Cancer

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Panel of oncology experts discussing the clinical impact of RASolution 302 in doubling patient survival.

Clinical Insights

06/15/2026

Doubling Survival: The Clinical Impact of RASolute 302

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Panel discussion on drug development and clinical success in RAS-driven cancer, featuring experts Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, and Dr.

Clinical Insights

06/14/2026

From Drug Design to Phase 3 Success in RAS-Driven Disease

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBA
Panel discussion on RAS inhibitors' emerging role in pancreatic cancer featuring Dr. Michael A. Morse, Dr. Midhun Malla, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Benjamin Musher, and Dr. Janie Y. Zhang.

Clinical Insights

06/13/2026

The Emerging Role of RAS Inhibitors in Pancreatic Cancer

Midhun Malla, MDMichael A. Morse, MD, FACP, MHSBenjamin Leon Musher, MDJanie Y. Zhang, MDRahul Gosain, MD, MBARohit Gosain, MD
Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, Dr. Shubham Panti discuss Daraxonrasib's impact on pancreatic cancer survival.

Clinical Insights

06/13/2026

Daraxonrasib Delivers Breakthrough Survival Gains in Pancreatic Cancer

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Panel discussion on dose optimization and pharmacogenomic testing for pancreatic cancer treatment featuring Dr. Michael A. Morse, Dr. Midhun Malla, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Benjamin Mus.

Clinical Insights

06/12/2026

Dose Optimization and Pharmacogenomic Testing in Pancreatic Cancer Treatment

Midhun Malla, MDMichael A. Morse, MD, FACP, MHSBenjamin Leon Musher, MDJanie Y. Zhang, MDRahul Gosain, MD, MBARohit Gosain, MD
Expert panel discussing recent advances in Luspatercept treatment for LR-MDS, highlighting evolving strategies and clinical insights.

Clinical Insights

06/12/2026

The Treatment Paradigm for Low-Risk MDS and the Impact of Luspatercept

Christopher Benton, MDJamile M. Shammo, MDTiffany Tanaka, MDAmer Zeidan, MBBS, MDRohit Gosain, MD
Group of medical professionals discussing real-world safety and care coordination for CAR T-cell therapy, featuring Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Surbhi Sidana, Dr. Ajai Chari, and Dr. Binod.

Clinical Insights

06/12/2026

Multiple Myeloma Experts Highlight Real-World Safety and Care Coordination Following CAR T-Cell Therapy

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of medical experts discussing immunotherapy, bladder cancer, and multidisciplinary care for non-muscle invasive bladder cancer (NMIBC).

Clinical Insights

06/11/2026

Real-World Integration, Immune Toxicity, and the Future of Multidisciplinary NMIBC Care

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD
Panel discussion on treatment options and future research in polycythemia vera featuring Dr. Anand Patel, Dr. Aaron Gerds, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Anthony Hunter.

Clinical Insights

06/11/2026

Treatment Selection and Future Directions in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of multiple myeloma experts discussing CAR T and BCMA therapies, including Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Surbhi Sidana, Dr. Binod Dhakal, and Dr. Ajai Chari, during a virtual conferenc.

Clinical Insights

06/11/2026

CAR T vs BCMA-Directed Bispecific Antibodies: Multiple Myeloma Experts Share Sequencing Insights

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of four doctors discussing molecular responses and long-term disease control in polycythemia vera, highlighting recent research and treatment strategies.

Clinical Insights

06/10/2026

Molecular Responses and Long-Term Disease Control in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Innovative CAR T-cell therapy for relapsed or refractory multiple myeloma, featuring expert insights from Dr. Surbhi Sidana, Dr. Rahul Gosain, Dr. Ajai Chari, and Dr. Binod Dhakal.

Clinical Insights

06/10/2026

CAR T-Cell Therapy Moves Earlier in Relapsed/Refractory Multiple Myeloma

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of four doctors discussing treatment strategies for polycythemia vera, focusing on optimizing ropeginterferon therapy, with a city skyline background.

Clinical Insights

06/09/2026

Optimizing Ropeginterferon Use in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Medical panel discussing Potomac trial results on Durvalumab and BCG therapy improving recurrence-free survival in cancer patients.

Clinical Insights

06/09/2026

POTOMAC Trial Breakthrough: Durvalumab Plus BCG Shows Improved Recurrence-Free Survival

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD
Key oncology trial highlights Durvalumab and BCG combination improving disease-free survival, featuring experts Dr. Shilpa Gupta, Dr. Neal Shore, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Amit Patel.

Clinical Insights

06/09/2026

POTOMAC Trial Breakthrough: Durvalumab Plus BCG Shows Improved Disease-Free Survival

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD
Panel discussion on high-risk non-muscle invasive bladder cancer (NMIBC) and BCG treatment limits featuring Dr. Shilpa Gupta, Dr. Neal Shore, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Amit Patel.

Clinical Insights

06/08/2026

Defining High-Risk Non–Muscle-Invasive Bladder Cancer and the Limits of BCG Alone

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD
Panel of four doctors discussing current treatment paradigms and the emerging role of Ropiginterferon in polycythemia vera (PV) at OncUpdates.

Clinical Insights

06/08/2026

Current Treatment Paradigms and the Emerging Role of Ropeginterferon Alfa-2b-njft in PV

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Experts discuss toxicity management and frontline evolution of Amivantamab in head and neck cancer treatment, featuring Dr. Barbara Burtness, Dr. Paul Swiecicki, and colleagues.

Clinical Insights

06/07/2026

Toxicity Management and Frontline Evolution of Amivantamab in Head and Neck Cancer

Barbara Burtness, MDPaul Swiecicki, MDAri Rosenberg, MDJessica Geiger, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel discussion on frontline therapy options for metastatic pancreatic adenocarcinoma featuring Dr. Michael Morse, Dr. Midhun Malla, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Benjamin Musher, and Dr. J.

Clinical Insights

06/06/2026

Choosing Frontline Therapy for Patients With Metastatic Pancreatic Adenocarcinoma

Midhun Malla, MDMichael A. Morse, MD, FACP, MHSBenjamin Leon Musher, MDJanie Y. Zhang, MDRahul Gosain, MD, MBARohit Gosain, MD
Experts discuss Amivantamab's promising activity in heavily pretreated cancer patients, highlighting recent clinical findings and future therapeutic potential.

Clinical Insights

06/06/2026

Amivantamab Demonstrates Promising Activity in Heavily Pretreated Disease

Barbara Burtness, MDPaul Swiecicki, MDAri Rosenberg, MDJessica Geiger, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of medical experts discussing frontline treatment options for metastatic pancreatic cancer, including Dr. Michael A. Morse, Dr. Midhun Malla, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Benjamin Mus.

Clinical Insights

06/05/2026

Frontline Treatment Selection in Metastatic Pancreatic Cancer

Midhun Malla, MDMichael A. Morse, MD, FACP, MHSBenjamin Leon Musher, MDJanie Y. Zhang, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of five medical experts discussing recurrent metastatic head and neck cancer, highlighting recent research and treatment strategies.

Clinical Insights

06/05/2026

Defining the Current Landscape in Recurrent Metastatic Head and Neck Cancer

Barbara Burtness, MDPaul Swiecicki, MDAri Rosenberg, MDJessica Geiger, MDRahul Gosain, MD, MBARohit Gosain, MD
Close-up of Verenzo (bevemacil) 50 mg tablets in packaging, used for erectile dysfunction treatment, displayed on a white background.

Clinical Insights

06/05/2026

CAR T in Myeloma: Earlier Use and Sequencing Insights from ASCO 2026

Binod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of oncology experts discussing the integration of Durvalumab into non-muscle invasive bladder cancer (NMIBC) treatment strategies.

Clinical Insights

06/04/2026

Clinical Insights: Integrating Durvalumab Into Non–Muscle-Invasive Bladder Cancer Care

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD
Expert discussion on the role of Amivantamab in treating head and neck cancer, featuring leading oncologists Dr. Barbara Burtness, Dr. Paul Swiecicki, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Ari Rosen.

Clinical Insights

06/02/2026

Clinical Insights: Role of Amivantamab in Head and Neck Cancer

Barbara Burtness, MDAri Rosenberg, MDJessica Geiger, MDPaul Swiecicki, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of medical experts discussing the impact of RASolute 302 on clinical practice for metastatic pancreatic ductal adenocarcinoma (PDAC).

Clinical Insights

06/02/2026

Clinical Insights: Impact of RASolute 302 on Clinical Practice in Previously Treated Metastatic PDAC

Andrew H. Ko, MDShubham Pant, MD, MBBSEileen O'Reilly, MDRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Panel of oncology experts discussing recent advances in metastatic pancreatic cancer treatment and research.

Clinical Insights

05/31/2026

Clinical Insights: Evolving Paradigms in Metastatic Pancreatic Cancer

Midhun Malla, MDMichael A. Morse, MD, FACP, MHSBenjamin Leon Musher, MDJanie Y. Zhang, MDRahul Gosain, MD, MBARohit Gosain, MD
Experts discuss the role of Ropoginterferon Alfa-2b in treating Polycythemia Vera, highlighting recent clinical insights and therapeutic strategies.

Clinical Insights

05/31/2026

Clinical Insights: Role of Ropeginterferon Alfa-2b-njft in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Time Toxicity, CNS Risk, and Sequencing Strategy in EGFR-Mutant NSCLC - OncUpdates featuring Dr. Julia Rotow, Dr. Fawzi Abu Rous, Dr. Sarah Goldberg, and Dr. Susan Scott discussing recent advances in.

Clinical Insights

03/19/2026

Ep. 3: Time Toxicity, CNS Risk, and Sequencing Strategy in EGFR-Mutant NSCLC

Eric Singhi, MDSarah Goldberg, MD, MPHFawzi Abu Rous, MDJulia Rotow, MDSusan Scott, MD
Proactive toxicity management and CNS control in EGFR-mutant NSCLC discussed by leading oncologists at OncUpdates conference. Expert insights on personalized treatment strategies.

Clinical Insights

03/17/2026

Ep. 2: Clinical Insights: Proactive Toxicity Management and CNS Control in EGFR-Mutant NSCLC

Eric Singhi, MDSarah Goldberg, MD, MPHSusan Scott, MDFawzi Abu Rous, MDJulia Rotow, MD
Accelerated cancer treatment strategies and CNS management in EGFR-mutant NSCLC featuring experts Chinmay Jani, MD, and Luis Raez, MD, at OncUpdates conference.

Clinical Insights

03/15/2026

Ep. 3: Intensification Strategies and CNS Management in EGFR-Mutant NSCLC

Chinmay Jani, MDLuis Raez, MD, FACP, FCCP, FASCO
Advanced multidisciplinary approaches to emerging bladder cancer treatments featuring leading experts Dr. Matt Galsky, Dr. Sia Daneshmand, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Chad Reichard, and Dr.

Clinical Insights

03/15/2026

Ep. 4: Multidisciplinary Approaches to Emerging Bladder Cancer Treatments

Rahul Gosain, MD, MBARohit Gosain, MDMatt Galsky, MDSia Daneshmand, MDChad Reichard, MDShilpa Gupta, MD
OS Benefit and Patient-Centered Delivery Advances in EGFR-Positive NSCLC, featuring Dr. Eric Singhi, Dr. Julia Rotow, Dr. Susan Scott, Dr. Sarah Goldberg, and Dr. Fawzi Abu Rous discussing recent onco.

Clinical Insights

03/14/2026

Ep. 1: OS Benefit and Patient-Centered Delivery Advances in EGFR-Mutant NSCLC

Eric Singhi, MDSusan Scott, MDSarah Goldberg, MD, MPHFawzi Abu Rous, MDJulia Rotow, MD
Advanced medical team discussing innovative approaches to perioperative ADC and immunotherapy in muscle-invasive bladder cancer.

Clinical Insights

03/14/2026

Ep. 3: Optimizing Perioperative ADC and Immunotherapy in Muscle-Invasive Bladder Cancer

Rahul Gosain, MD, MBARohit Gosain, MDMatt Galsky, MDSia Daneshmand, MDChad Reichard, MDShilpa Gupta, MD
Advanced medical professionals Luis Raez, MD, and Chinmay Jani, MD, discuss the latest advancements in subcutaneous Amivantamab reshaping frontline EGFR-mutant NSCLC care.

Clinical Insights

03/13/2026

Ep. 2: Subcutaneous Amivantamab Reshapes Frontline EGFR-Mutant NSCLC Care

Chinmay Jani, MDLuis Raez, MD, FACP, FCCP, FASCO
Advanced cancer specialists discussing systemic therapy and radical cystectomy in MIBC at OncUpdates conference. Expert panel includes Dr. Matt Galsky, Dr. Sia Daneshmand, Dr. Chad Reichard, Dr. Shilp.

Clinical Insights

03/12/2026

Ep. 2: Coordinating Systemic Therapy and Radical Cystectomy in Muscle-Invasive Bladder Cancer

Rahul Gosain, MD, MBARohit Gosain, MDMatt Galsky, MDSia Daneshmand, MDChad Reichard, MDShilpa Gupta, MD
Shifting the Treatment Landscape in MIBC with Expert Oncologists and Innovative Approaches for Bladder Cancer Management.

Clinical Insights

03/11/2026

Ep. 1: NIAGARA: Shifting the Treatment Landscape in Muscle-Invasive Bladder Cancer

Rahul Gosain, MD, MBARohit Gosain, MDMatt Galsky, MDShilpa Gupta, MDSia Daneshmand, MDChad Reichard, MD
Overcoming infusion barriers in EGFR-mutant non-small cell lung cancer with expert insights from Luis Raez, MD, and Chinmay Jani, MD, at OncUpdates conference.

Clinical Insights

03/11/2026

Ep. 1: Overcoming Infusion Barriers in EGFR-Mutant Non–Small Cell Lung Cancer

Chinmay Jani, MDLuis Raez, MD, FACP, FCCP, FASCO
Expert panel discussing evolving clinical insights in bladder cancer with Dr. Shilpa Gupta, Dr. Chad Reichard, Dr. Sia Daneshmand, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Matt Galsky.

Clinical Insights

03/09/2026

Clinical Insights: Evolving Landscapes in MIBC and NMIBC

Rahul Gosain, MD, MBARohit Gosain, MDShilpa Gupta, MDChad Reichard, MDSia Daneshmand, MDMatt Galsky, MD
Panel of oncology experts discussing next-line treatment strategies for Durvalumab in gastric and GEJ cancer, highlighting clinical insights and practice updates.

Clinical Insights

02/02/2026

Ep. 4: Next-Line Strategies and Practice Insights for Durvalumab in Gastric and GEJ Cancer

Rahul Gosain, MD, MBARohit Gosain, MDAngela Alistar, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD
Sequencing and next steps for Zanidatamab in HER2-positive gastric cancer with expert oncologists Dr. Manish Shah, Dr. Geoffrey Ku, Dr. Nataliya Uboha, Dr. Rutika Mehta, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Clinical Insights

02/01/2026

Ep. 4: Sequencing and Next Steps for Zanidatamab in HER2-Positive Gastric Cancer

Rahul Gosain, MD, MBARohit Gosain, MDGeoffrey Ku, MDRutika Mehta, MD, MB, MPHManish Shah, MDNataliya Uboha, MD, PhD
1. Expert panel on balancing therapy intensity and patient tolerability in gastric cancer featuring OncUpdates specialists.

Clinical Insights

01/31/2026

Ep. 3: Balancing Therapy Intensity and Patient Tolerability in Gastric and GEJ Cancer

Rahul Gosain, MD, MBARohit Gosain, MDAngela Alistar, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD
HER2-targeted cancer treatment research panel featuring Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Nataliya Uboha, Dr. Rutika Mehta, Dr. Geoffrey Ku, and Dr. Manish Shah discussing HERZON-GEA-01 infusion and GI management for zanidatamab.

Clinical Insights

01/30/2026

Ep. 3: HERIZON-GEA-01: Infusion and GI Management for Zanidatamab

Rahul Gosain, MD, MBARohit Gosain, MDGeoffrey Ku, MDRutika Mehta, MD, MB, MPHManish Shah, MDNataliya Uboha, MD, PhD
1. Upfront PD-L1 testing and perioperative immunotherapy for gastric cancer with oncology experts from OncUpdates.

Clinical Insights

01/29/2026

Ep. 2: Up-Front PD-L1 Testing and Perioperative Immunotherapy in Gastric and GEJ Cancer

Rahul Gosain, MD, MBARohit Gosain, MDAngela Alistar, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD
1. OncUpdates episode 2 featuring oncology experts discussing managing efficacy and toxicity of Zanidatamab in HER2-positive cancer.

Clinical Insights

01/28/2026

Ep. 2: Managing Efficacy and Toxicity With Zanidatamab in HER2-Positive Disease

Rahul Gosain, MD, MBARohit Gosain, MDGeoffrey Ku, MDRutika Mehta, MD, MB, MPHManish Shah, MDNataliya Uboha, MD, PhD
1. Expert medical professionals discussing perioperative dervalimbal in gastric and GEJ cancer for advanced oncology treatment insights.

Clinical Insights

01/27/2026

Ep. 1: Clinical Insights on Perioperative Durvalumab in Gastric and GEJ Cancer

Rahul Gosain, MD, MBARohit Gosain, MDAngela Alistar, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD
Zanidatamab first-line therapy for HER2-positive upper GI malignancies discussed by expert panel including Dr. Geoffrey Ku, Dr. Manish Shah, Dr. Natalya Uboha, Dr. Rutika Mehta, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Clinical Insights

01/26/2026

Ep. 1: Zanidatamab Redefines First-Line Therapy in HER2-Positive Upper GI Malignancies

Rahul Gosain, MD, MBARohit Gosain, MDGeoffrey Ku, MDRutika Mehta, MD, MB, MPHManish Shah, MDNataliya Uboha, MD, PhD
1. OncUpdates article on perioperative Durvalumab and FLOT chemotherapy for resectable gastric and GEJ adenocarcinoma featuring expert doctors from OncUpdates.

Clinical Insights

01/21/2026

Perioperative Durvalumab: The New Standard for Gastric or GEJ Cancer

Angela Alistar, MDRahul Gosain, MD, MBARohit Gosain, MDSteven Maron, MD, MScReetu Mukherji, MDRaji Shameem, MD
Zanidatamab frontline therapy for HER2-positive gastric and GEJ cancer expert panel with Dr. Rutika Mehta, Dr. Nataliya Uboha, Dr. Manish Shah, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Geoffrey Ku.

Clinical Insights

01/20/2026

HERIZON-GEA-01: Zanidatamab for HER2+ Advanced Gastroesophageal Cancer

Rahul Gosain, MD, MBARohit Gosain, MDGeoffrey Ku, MDRutika Mehta, MD, MB, MPHManish Shah, MDNataliya Uboha, MD, PhD
CNS activity and sequencing strategies for Dato-DXd in EGFR-mutated NSCLC featuring expert oncologists from OncUpdates.

Clinical Insights

01/14/2026

Ep. 5: CNS Activity and Sequencing Strategies for Datopotamab Deruxtecan in EGFR-Mutant NSCLC

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates presentation on Ribociclib and oral SERDs in high-risk cancer disease featuring expert oncologists and researchers.

Clinical Insights

01/14/2026

Ep. 4: Ribociclib and the Evolving Role of Oral SERDs in High-Risk Disease

Laura Huppert, MDKomal Jhaveri, MD, FACPHeather McArthur, MDHope Rugo, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
1. Expert oncologists Dr. Aaron Lisberg, Dr. Sarah Sunshine, Dr. Blanca Ledezma, Dr. Rahul Gosain, and Dr. Rohit Gosain discuss Dato-DXd in EGFR-Mutant NSCLC for community-based monitoring and toxicity management.

Clinical Insights

01/13/2026

Ep. 4: Datopotamab Deruxtecan in EGFR-Mutated NSCLC: Community-Based Monitoring and Toxicity Management

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. Expert oncology researchers discussing monitoring, dosing, and rechallenge strategies in EGFR-mutated NSCLC during a conference panel.

Clinical Insights

01/12/2026

EP. 3: Monitoring, Dosing, and Rechallenge Strategies With Datopotamab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
OncUpdates panel discussing Abemaciclib vs Ribociclib for clinical decision-making and improving quality of life in cancer patients, featuring expert oncologists Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Laura Huppert, Dr. Komal Jhaveri, Dr. Hope Rugo, and Dr. Heather McArthur.

Clinical Insights

01/12/2026

Ep. 3: Abemaciclib vs Ribociclib: Clinical Decision-Making for Quality of Life

Laura Huppert, MDKomal Jhaveri, MD, FACPHeather McArthur, MDHope Rugo, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
1. Expert oncology panel discussing practical strategies for managing ocular, oral, and pulmonary toxicities with Dato-DXd in cancer treatment.

Clinical Insights

01/11/2026

Ep. 2: Managing Ocular Toxicity, Mucositis, and ILD With Datopotamab Deruxtecan in EGFR-Mutated NSCLC

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates panel discussing metastatic HR+ breast cancer and CDK4/6 inhibitor treatment options with leading oncology experts.

Clinical Insights

01/10/2026

Ep. 2: Metastatic HR-Positive Breast Cancer: Choosing the Right CDK4/6 Inhibitor

Laura Huppert, MDKomal Jhaveri, MD, FACPHeather McArthur, MDHope Rugo, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
1. Expert panel discussing managing fatigue and phlebotomy burden in pulmonary embolism patients using Rusteride at OncUpdates conference.

Clinical Insights

01/10/2026

Ep. 4: Managing Fatigue and Phlebotomy Burden in PV With Rusfertide

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD
1. Team of medical researchers and oncologists discussing efficacy, safety, and management of data-driven targeted therapy (DAtDX) in EGFR-mutated lung cancer.

Clinical Insights

01/09/2026

Ep. 1: Efficacy, Safety, and Management of Dato-DXd in EGFR-Mutated Lung Cancer

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
Early-Stage HR+ Breast Cancer treatment update on managing CDK4/6 inhibitor sequencing with expert physicians at OncUpdates.

Clinical Insights

01/09/2026

Ep. 4: Early-Stage HR-Positive Breast Cancer: Managing CDK4/6 Inhibitor Sequencing

Sara Hurvitz, MD, FACPSherry Shen, MDEleanora Teplinsky, MDRahul Gosain, MD, MBARohit Gosain, MD
Managing Hematocrit and Symptoms in PV: Dose Titration Strategies for Rusfertide.

Clinical Insights

01/08/2026

Ep. 3: Managing Hematocrit and Symptoms in PV: Dose-Titration Strategies for Rusfertide

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD
Liver toxicity research with expert doctors discussing risk stratification and personalized adjuvant therapy in early-stage HR+ breast cancer treatment.

Clinical Insights

01/07/2026

Ep. 3: Liver Toxicity, Risk Stratification, and Personalized Adjuvant Therapy in Early-Stage HR-Positive Disease

Sara Hurvitz, MD, FACPSherry Shen, MDEleanora Teplinsky, MDRahul Gosain, MD, MBARohit Gosain, MD
OncUpdates medical experts discussing clinical insights on optimizing Ribociclib, Abemaciclib, and Palbociclib for cancer treatment.

Clinical Insights

01/06/2026

Ep. 1: Clinical Insights: Optimizing Ribociclib, Abemaciclib, and Palbociclib Use in Metastatic HR-Positive Breast Cancer

Laura Huppert, MDKomal Jhaveri, MD, FACPHeather McArthur, MDHope Rugo, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
1. A group of medical researchers and doctors discussing cancer treatment algorithms in a professional conference setting.

Clinical Insights

01/06/2026

Ep. 2: Integrating Rusfertide Into the Polycythemia Vera Treatment Algorithm

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD
1. Expert panel on practical guidance for Ribociclib and Abemaciclib in adjuvant cancer therapy, featuring leading oncologists discussing advanced treatment strategies.

Clinical Insights

01/05/2026

Ep. 2: Practical Guidance for Ribociclib and Abemaciclib in the Adjuvant Setting

Sara Hurvitz, MD, FACPSherry Shen, MDEleanora Teplinsky, MDRahul Gosain, MD, MBARohit Gosain, MD
Adjuvant Ribociclib in early-stage HR+ breast cancer clinical insights featuring expert doctors and research leaders.

Clinical Insights

01/03/2026

Ep. 1: Adjuvant Ribociclib in Early-Stage HR-Positive Breast Cancer: Clinical Insights

Sara Hurvitz, MD, FACPSherry Shen, MDEleanora Teplinsky, MDRahul Gosain, MD, MBARohit Gosain, MD
1. Innovative hematocrit control approaches in polycythemia vera presented by leading oncology experts for improved patient management.

Clinical Insights

01/02/2026

Ep. 1: Clinical Insights: New Approaches to Hematocrit Control in Polycythemia Vera

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD
1. Expert medical team discussing clinical insights on Dato-DXd in EGFR-mutated NSCLC for oncology research and treatment advancements.

Clinical Insights

12/31/2025

Multidisciplinary Strategies for Dato-DXd in Pretreated EGFR-Mutated Advanced NSCLC (Full Video)

Aaron Lisberg, MDSarah Sunshine, MDBlanca Ledezma, NPRahul Gosain, MD, MBARohit Gosain, MD
1. Expert panel discusses CDK4/6 inhibitors in metastatic breast cancer at OncUpdates, featuring leading oncologists and researchers.

Clinical Insights

12/31/2025

CDK4/6 Inhibitor Selection in HR+ Metastatic Breast Cancer (Full Video)

Laura Huppert, MDKomal Jhaveri, MD, FACPHeather McArthur, MDHope Rugo, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates panel featuring leading oncologists discussing advances in EGFR-Mutant NSCLC treatment strategies.

Clinical Insights

12/30/2025

EP. 5: Closing Perspectives on Advancing Care in EGFR-Positive NSCLC

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
Advances in managing toxicities in Mariposa including IRRs, VTEs, and rash with expert strategies by Dr. Joshua Sabari, Dr. Danny Nguyen, Dr. Alexander Spira, and Dr. Edgardo Santos, featured on OncUpdates.

Clinical Insights

12/29/2025

Ep. 4: Managing Toxicities in MARIPOSA: Mitigating Treatment-Related Adverse Events

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
OncUpdates panel discussing clinical insights on escalation versus de-escalation in EGFR-positive NSCLC with doctors Joshua Sabari, Danny Nguyen, Alexander Spira, Edgardo Santos, and Eric Singhi.

Clinical Insights

12/27/2025

Ep. 3: Clinical Insights: Escalation vs De-escalation in EGFR-Positive NSCLC

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
Polycythemia Vera management insights, hematocrit control, and clinical treatment strategies by Dr. Andrew Kuykendall, Dr. Aaron Gerds, Dr. Talha Badar, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Clinical Insights

12/22/2025

Clinical Insights: VERIFY Trial Shows Rusfertide’s Potential to Transform PV Treatment (Full Video)

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD
1. Expert panel on CNS activity and resistance discussing Amivantamab and Lazertinib for cancer treatment with Dr. Joshua Sabari, Dr. Edgardo Santos, Dr. Eric Singhi, and Dr. Alexander Spira.

Clinical Insights

12/21/2025

Ep. 2: CNS Control and Resistance: Panel Examines Amivantamab Plus Lazertinib

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
Adjuvant CDK4/6 therapy in early HR+ breast cancer, featuring Dr. Eleonora Teplinsky, Dr. Sherry Shen, Dr. Rahul Gosain, Dr. Sara Hurwitz, and Dr. Rohit Gosain, with clinical insights and expertise.

Clinical Insights

12/20/2025

Adjuvant Ribociclib and Abemaciclib in Early HR+ Breast Cancer (Full Video)

Eleanora Teplinsky, MDSara Hurvitz, MD, FACPSherry Shen, MDRahul Gosain, MD, MBARohit Gosain, MD
EGFR-Mutant NSCLC survival updates featuring experts Dr. Danny Nguyen, Dr. Eric Singhi, Dr. Alexander Spira, Dr. Edgardo Santos, and Dr. Joshua Sabari discussing Mariposa & FLAURA2 studies.

Clinical Insights

12/19/2025

Ep. 1: Overall Survival Updates in EGFR-Positive NSCLC: MARIPOSA and FLAURA2

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
EGFR+ NSCLC metastatic cancer research researchers Dr. Joshua Sabari Dr. Danny Nguyen Dr. Eric Singhi Dr. Alexander Spira Dr. Edgardo Santos oncology clinical insights oncology updates.

Clinical Insights

12/16/2025

Clinical Insights: Metastatic EGFR+ NSCLC from MARIPOSA and PALOMA-3

Joshua Sabari, MDAlexander Spira, MD, PhD, FACP, FASCODanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MD
Optimizing Sequential Therapy in Advanced RCC with expert team including Dr. David Braun, Dr. Ulka Vaishampayan, Dr. Bradley McGregor, Dr. Rohit Gosain, and Dr. Rahul Gosain for oncology research and treatment advancements.

Clinical Insights

12/11/2025

Ep. 5: Optimizing Sequential Therapy in Advanced RCC

Bradley McGregor, MDUlka Vaishampayan, MBBSDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Second-line RCC management, tolerability, comorbidities, long-term planning expert panel discussion at OncUpdates. Featuring Dr. Bradley McGregor, Dr. David Braun, Dr. Ulka Vaishampayan, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Clinical Insights

12/10/2025

Ep. 4: Second-Line RCC Management: Tolerability, Comorbidities, and Long-Term Planning

Ulka Vaishampayan, MBBSBradley McGregor, MDDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates panel discussion on balancing patient goals and efficacy in second-line RCC therapy featuring leading oncologists.

Clinical Insights

12/09/2025

Ep. 3: Balancing Patient Goals and Efficacy in Second-Line RCC Therapy

David Braun, MD, PhDUlka Vaishampayan, MBBSBradley McGregor, MDRahul Gosain, MD, MBARohit Gosain, MD
VEGF TKIs in RCC research panel featuring Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. David Braun, and Dr. Bradley McGregor discussing toxicity and tolerability in renal cell carcinoma therapies.

Clinical Insights

12/08/2025

Ep. 2: VEGF TKIs in RCC: Toxicity and Tolerability

David Braun, MD, PhDBradley McGregor, MDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates logo featuring expert healthcare professionals discussing Tivozanib in the current RCC treatment landscape, enhancing oncology and targeted therapy awareness.

Clinical Insights

12/07/2025

Ep. 1: Positioning Tivozanib in Today’s RCC Treatment Landscape

Ulka Vaishampayan, MBBSDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates panel discussion on treating advanced renal cell carcinoma (RCC) after first-line therapy with leading oncologists.

Clinical Insights

12/06/2025

Treating Advanced RCC After First-Line Therapy (Full Video)

David Braun, MD, PhDBradley McGregor, MDUlka Vaishampayan, MBBSRahul Gosain, MD, MBARohit Gosain, MD
In-depth analysis of key insights from IMforTe regarding treating ES-SCLC with expert clinicians Dr. Stephen Liu, Dr. Ticiana Leal, Dr. Isabel Preeshagul, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Clinical Insights

10/19/2025

EP. 6: Key Takeaways From IMforte for Clinicians Treating ES-SCLC

Ticiana Leal, MDStephen Liu, MDIsabel Preeshagul, DO, MBSRahul Gosain, MD, MBARohit Gosain, MD
Sequencing Lurbinectedin in ES-SCLC with CNS Involvement - OncUpdates featuring Dr. Stephen Liu, Dr. Ticiana Leal, Dr. Rahul Gosain, and Dr. Rohit Gosain focusing on recent advancements in small cell lung cancer treatment.

Clinical Insights

10/17/2025

EP. 5: Sequencing Lurbinectedin in ES-SCLC with CNS Involvement

Ticiana Leal, MDStephen Liu, MDRahul Gosain, MD, MBARohit Gosain, MD
Lurinctedin adverse events management in ES-SCLC maintenance therapy with expert doctors Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Isabel Preeshagul, and Dr. Stephen Liu, from OncUpdates.

Clinical Insights

10/15/2025

EP. 4: Managing Lurbinectedin Adverse Events in ES-SCLC Maintenance Therapy

Isabel Preeshagul, DO, MBSStephen Liu, MDRahul Gosain, MD, MBARohit Gosain, MD
Immunotherapy and clinical research experts discussing the clinical relevance of IMforTE survival data in ES-SCLC. Featuring Dr. Ticiana Leal, Dr. Stephen Liu, Dr. Rahul Gosain, and Dr. Rohit Gosain at OncUpdates.

Clinical Insights

10/13/2025

Ep. 3: Clinical Relevance of IMforte Survival Data in ES-SCLC

Ticiana Leal, MDStephen Liu, MDRahul Gosain, MD, MBARohit Gosain, MD
Efficacy outcomes in the IMforte trial featuring Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Stephen Liu, highlighting PFS, OS, and clinical impact for cancer treatment advancements.

Clinical Insights

10/11/2025

Ep. 2: Efficacy Outcomes in the IMforte Trial: PFS, OS, and Clinical Impact

Stephen Liu, MDRahul Gosain, MD, MBARohit Gosain, MD
IMforte Study Design and Maintenance Approach in ES-SCLC

Clinical Insights

10/10/2025

Ep. 1: IMforte Study Design and Maintenance Approach in ES-SCLC

Isabel Preeshagul, DO, MBSRahul Gosain, MD, MBARohit Gosain, MD
Lurbinectedin first-line maintenance therapy for small cell lung cancer, featuring expert oncologists discussing extensive-stage treatment options and latest research.

Clinical Insights

10/06/2025

IMforte: Maintenance With Lurbinectedin in Newly Diagnosed ES-SCLC (Full Video)

Rohit Gosain, MDRahul Gosain, MD, MBAStephen Liu, MDTiciana Leal, MDIsabel Preeshagul, DO, MBS
Expert panel discussion on cancer research and oncology advancements at OncUpdates.

Clinical Insights

06/16/2025

EP. 6: Practice-Changing Insights From the NIAGARA Trial

Petros Grivas, MD, PhD
Innovative oncology discussion featuring medical experts sharing insights on cancer treatment strategies at OncUpdates conference.

Clinical Insights

06/16/2025

Ep. 3: How to Choose the Best First-Line Therapy for Patients With EGFR-Mutated NSCLC

Susan Scott, MDEstelamari Rodriguez, MD, MPHHelena Yu, MD
Expert medical panel discussion on cancer updates and new treatment strategies at OncUpdates.

Clinical Insights

06/16/2025

Ep. 2: New Insights From the MARIPOSA Trial: Amivantamab Plus Lazertinib for EGFR-Mutated NSCLC

Helena Yu, MDJoshua Sabari, MD
Doctor and patient discussion about cancer treatment at OncUpdates conference, emphasizing oncology care and medical research.

Clinical Insights

06/16/2025

EP. 1: Targeted Therapies in EGFR-Mutated NSCLC: Managing Treatment-Related AEs

Estelamari Rodriguez, MD, MPHHelena Yu, MDJoshua Sabari, MD
Discussion panel on oncology research at OncUpdates, featuring medical experts sharing insights on cancer treatment advancements and latest breakthroughs in oncology.

Clinical Insights

06/16/2025

Ep. 5: NIAGARA Trial: Perioperative Durvalumab Enhances DFS in MIBC

Joshua Meeks, MD, PhD
Expert panel discussion on oncology research and recent advancements in cancer treatment.

Clinical Insights

06/16/2025

Ep. 4: The Oncologist’s Role in Counseling Patients With MIBC Through Complex Treatment Decisions

Karine Tawagi, MD
High-level discussion on oncology research and cancer treatment advancements at OncUpdates conference. Experts share insights on innovative therapies and patient care strategies.

Clinical Insights

06/16/2025

Ep. 3: Key Takeaways From the NIAGARA Trial for Patients With MIBC

Neal Shore, MD, FACS
In-depth interview with medical experts discussing latest advancements in cancer treatment and research, focusing on patient care, innovative therapies, and clinical trial updates.

Clinical Insights

06/16/2025

Ep. 1: Current Treatment Strategies for Muscle-Invasive Bladder Cancer

Karine Tawagi, MD
Lecture on cancer treatment innovations discussed among medical professionals.

Clinical Insights

06/16/2025

Ep. 2: Clinical Implications of Circulating Tumor DNA in MIBC

Petros Grivas, MD, PhDJoshua Meeks, MD, PhD
Mariposa: Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC - Oncology research featuring leading doctors discussing advanced lung cancer treatment options and targeted therapies.

Clinical Insights

06/15/2025

MARIPOSA: Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC

Estelamari Rodriguez, MD, MPHHelena Yu, MDJoshua Sabari, MDSusan Scott, MDRahul Gosain, MD, MBARohit Gosain, MD
1. Expert oncologists presenting research on NIAGARA trial and perioperative durvalumab treatment for MIBC.

Clinical Insights

06/14/2025

NIAGARA Trial: Perioperative Durvalumab for MIBC (Full Video)

Joshua Meeks, MD, PhDKarine Tawagi, MDNeal Shore, MD, FACSPetros Grivas, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD

Treatment Algorithms

View All
Medical professionals discussing treatment options for BRAF V600E-mutated NSCLC, highlighting personalized approaches and targeted therapies for lung cancer patients.

Treatment Algorithm

05/26/2026

How To Select Between Treatment Options for BRAF V600E–Mutated NSCLC

Gregory Riely, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Advanced frontline therapy for metastatic NSCLC without actionable mutations.

Treatment Algorithm

05/18/2026

The Frontline Treatment Algorithm for Metastatic NSCLC Without Actionable Mutations

Chirstine Garcia, MD, MPHRahul Gosain, MD, MBARohit Gosain, MD
Dr. Eric Singhi smiling in a professional portrait, with two other doctors discussing targeted therapies for metastatic non-small cell lung cancer (NSCLC) with actionable mutations.

Treatment Algorithm

05/15/2026

Frontline Treatments for Metastatic NSCLC With Actionable Mutations 

Eric Singhi, MDRahul Gosain, MD, MBARohit Gosain, MD
Expert medical team discussing curative treatment options for early-stage non-small cell lung cancer (NSCLC).

Treatment Algorithm

05/11/2026

Standard of Care Curative Treatments for Early-Stage NSCLC

Sanjay Popat, FRCP, PhDRahul Gosain, MD, MBARohit Gosain, MD
Overview of treatment standards for small cell lung cancer (SCLC) across limited- and extensive-stage disease, highlighting current care practices and expert insights.

Treatment Algorithm

05/05/2026

Standard of Care in SCLC: Treatment Across Limited- and Extensive-Stage Disease

Jacob Sands, MDRahul Gosain, MD, MBARohit Gosain, MD
An image showing Dr. Smitha Krishnamurthi and colleagues discussing colorectal cancer treatment standards.

Treatment Algorithm

04/27/2026

Assessing the Current Standard of Care Treatment for Colorectal Cancer

Smitha Krishnamurthi, MDRahul Gosain, MD, MBARohit Gosain, MD
Medical professionals discussing the latest advancements in pancreatic cancer treatment algorithms, highlighting personalized approaches and innovative therapies.

Treatment Algorithm

04/21/2026

The Evolving Treatment Algorithm for Pancreatic Cancers

Shubham Pant, MD, MBBSRahul Gosain, MD, MBARohit Gosain, MD
Medical professionals analyze the current biliary tract cancer treatment algorithm to improve patient outcomes and update clinical practices.

Treatment Algorithm

04/15/2026

Doctors Review the Current Biliary Tract Cancer Treatment Algorithm

Suneel Kamath, MDRahul Gosain, MD, MBARohit Gosain, MD
Visual overview of the updated bladder cancer treatment algorithm featuring medical professionals Dr. Joshua Meeks, Dr. Stephanie Berg, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Treatment Algorithm

04/06/2026

The Updated Treatment Algorithm for Bladder Cancer

Stephanie Berg, DOJoshua Meeks, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
A woman doctor smiling, with text about reviewing RCC treatment algorithms and trial regimens, on a green background.

Treatment Algorithm

03/31/2026

Reviewing the RCC Treatment Algorithm and Novel Trial Regimens

Katy Beckermann, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Prostate cancer treatment experts review algorithms, featuring Dr. Scott Tagawa, Dr. Rohit Gosain, and Dr. Rahul Gosain, highlighting innovative approaches and recent advancements in oncology care.

Treatment Algorithm

03/26/2026

Experts Review Treatment Algorithms for Prostate Cancer

Scott Tagawa, MD, MS, FACP, FASCORahul Gosain, MD, MBARohit Gosain, MD
An informative image featuring Dr. Tiffany Traina and Dr. Rohit Gosain with Dr. Rahul Gosain, highlighting treatment algorithms across TNBC populations for oncology research and clinical practice.

Treatment Algorithm

03/18/2026

Treatment Algorithms Across TNBC Populations

Tiffany Traina, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
Advanced breast cancer treatment algorithm discussion featuring Dr. Virginia Kaklamani, Dr. Rohit Gosain, and Dr. Rahul Gosain, highlighting the evolving landscape of HER2-positive breast cancer manag.

Treatment Algorithm

03/06/2026

Treatment Algorithm: The Shifting Landscape of HER2-Positive Breast Cancer

Virginia Kaklamani, MD, DScRahul Gosain, MD, MBARohit Gosain, MD
Advanced cancer specialists discussing innovative treatment options for HR+ metastatic breast cancer at OncUpdates conference.

Treatment Algorithm

03/02/2026

Standard of Care Treatments for HR+ Metastatic Breast Cancer

Kevin Kalinsky, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Evolving treatment algorithms for early-stage hormone receptor-positive breast cancer research by Dr. Erica Mayer and colleagues.

Treatment Algorithm

02/20/2026

Evolving Treatment Algorithms for Early-Stage Hormone Receptor–Positive Breast Cancer 

Erica Mayer, MD, MPHRahul Gosain, MD, MBARohit Gosain, MD
A woman smiling, representing Dr. Fangdi Sun, with a green background and text about current treatment pathways for head and neck cancers.

Treatment Algorithm

02/17/2026

The Current Treatment Pathways for Head and Neck Cancers

Fangdi Sun, MDRahul Gosain, MD, MBARohit Gosain, MD
Reviewing the metastatic colorectal cancer treatment algorithm with Dr. Rohit Gosain and Dr. Rahul Gosain, experts in oncology, on the OncUpdates platform.

Treatment Algorithm

02/16/2026

Reviewing the Metastatic Colorectal Cancer Treatment Algorithm

Rahul Gosain, MD, MBARohit Gosain, MD
Advanced cancer research team discussing clinical implications of HER2 testing and targeted therapies at OncUpdates.

Treatment Algorithm

02/09/2026

T-DXd and Interpreting HER2 Expression in HR+ Metastatic Breast Cancer

Komal Jhaveri, MD, FACPRahul Gosain, MD, MBARohit Gosain, MD
Expert oncology doctors discussing melanoma treatment options for the community oncology landscape at OncUpdates.

Treatment Algorithm

11/06/2025

Melanoma Treatment Algorithm for the Community Oncologist

Omid Hamid, MDRahul Gosain, MD, MBARohit Gosain, MD
1. Expert healthcare professionals discussing clinical strategies for cancer diagnosis and management at OncUpdates conference.

Treatment Algorithm

10/29/2025

NETs: Clinical Strategies for Diagnosis and Management

Thor Halfdanarson, MDRahul Gosain, MD, MBARohit Gosain, MD
Advanced ovarian cancer treatment algorithm analysis featuring Dr. Sharyn N. Lewin, Dr. Rohit Gosain, and Dr. Rahul Gosain, highlighting innovative approaches in ovarian cancer care.

Treatment Algorithm

10/27/2025

Unraveling the Treatment Algorithm for Ovarian Cancer

Sharyn N. Lewin, MDRahul Gosain, MD, MBARohit Gosain, MD
Dr. Jorge Cortes

Treatment Algorithm

10/14/2025

Treating CML in 2025: TKIs and Transplant

Jorge Cortes, MDRahul Gosain, MD, MBARohit Gosain, MD
OncUpdates theme focusing on colorectal cancer treatment and oncology advancements, featuring oncologists Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Mazyar Shadman for community oncology education.

Treatment Algorithm

09/11/2025

CLL Treatment Landscape for the Community Oncologist

Mazyar Shadman, MD, MPHRahul Gosain, MD, MBARohit Gosain, MD
Myelofibrosis treatment algorithm 2025, oncological updates by Dr. Raajit Rampal and experts in hematology and cancer research.

Treatment Algorithm

08/11/2025

Myelofibrosis Treatment Algorithm in 2025

Raajit Rampal, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Clinical strategies for diagnosing and treating multiple primary neoplasms (MPNs) in cancer patients, featuring expert insights from Dr. Andrew Kuykendall.

Treatment Algorithm

08/04/2025

Clinical Strategies for Diagnosing and Treating MPNs

Andrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD
Early stage non-small cell lung cancer treatment updates 2025 featuring Dr. Deepa Rangachari, Dr. Rohit Gosain, and Dr. Rahul Gosain for oncology professionals and patients.

Treatment Algorithm

07/29/2025

Reviewing Early-Stage NSCLC Treatments in 2025

Deepa Rangachari, MD
Men's health oncology treatment algorithm for AML in 2025, cancer treatment updates, hematology news, AML therapy advancements, Dr. Anand Patel.

Treatment Algorithm

07/24/2025

The Treatment Algorithm for AML in 2025

Anand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
DLBCL treatment algorithm 2025, oncological updates, lymphoma therapy, Dr. John Leonard, Dr. Rohit Gosain, Dr. Rahul Gosain, cancer treatment advancements, hematologic oncology, oncological research, latest lymphoma treatment strategies.

Treatment Algorithm

07/22/2025

The DLBCL Treatment Algorithm in 2025

John Leonard, MD
Frontline treatment for metastatic EGFR-mutated NSCLC discussed by leading oncologists at OncUpdates, featuring Dr. Susan Scott, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Treatment Algorithm

06/16/2025

Frontline Treatment for Metastatic EGFR-Mutated NSCLC

Susan Scott, MDRahul Gosain, MD, MBARohit Gosain, MD
OncUpdates latest research on targeted therapies for metastatic non-small cell lung cancer involving genetic mutations and personalized treatment options.

Treatment Algorithm

05/28/2025

Selecting Up-Front Treatments for NSCLC with Targetable Mutations

Susan Scott, MD
How to treat small cell lung cancer in 2025, onco updates, cancer treatment news, lung cancer therapy advancements, Dr. Ticiana Leal expert insights, small cell lung cancer prognosis 2025.

Treatment Algorithm

05/28/2025

Recent and Upcoming Advancements in Treatment Options for SCLC

Ticiana Leal, MD
Metastatic NSCLC treatment insights with Dr. Mark Awad, focusing on targeted therapies without mutations, featuring expert oncology discussions from OncUpdates.

Treatment Algorithm

05/16/2025

Frontline Treatment of Metastatic NSCLC Without Actionable Mutations

Mark Awad, MD, PhD

Challenging Cases

View All

Challenging cases

07/03/2026

Selecting Frontline and Subsequent Treatment Options for Metastatic RCC

Pedro Barata, MD, MSc, FACPRahul Gosain, MD, MBARohit Gosain, MD
Prominent oncology experts Dr. Shirish Gadgeel, Dr. Wade Iams, Dr. Rohit Gosain, and Dr. Rahul Gosain discuss advanced treatment and management options for mEGFR NSCLC patients.

Challenging cases

06/04/2026

Doctors Review Best Practices in Metastatic EGFR–Mutated NSCLC Cases

Rohit Gosain, MDRahul Gosain, MD, MBAShirish Gadgeel, MBBS, FASCOWade Iams, MD, MSCI
Prominent oncology experts Dr. Shirish Gadgeel, Dr. Wade Iams, Dr. Rohit Gosain, and Dr. Rahul Gosain discuss advanced treatment and management options for mEGFR NSCLC patients.

Challenging cases

06/04/2026

Experts Review Best Practices in Metastatic EGFR–Mutated NSCLC Cases

Shirish Gadgeel, MBBS, FASCOWade Iams, MD, MSCIRahul Gosain, MD, MBARohit Gosain, MD
Experts evaluate targeted therapies for relapsed or refractory AML in challenging cases, featuring Dr. Joshua Zeidner, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Challenging cases

05/27/2026

Experts Evaluate Targeted Therapies in Relapsed or Refractory AML

Joshua Zeidner, MDRahul Gosain, MD, MBARohit Gosain, MD
Dr. Fadi Haddad, Dr. Gabriela Hobbs, Dr. Rohit Gosain, and Dr. Rahul Gosain discuss challenging oncology cases, including frontline TKI for CML and treatment options.

Challenging cases

05/25/2026

Challenging Cases: Frontline TKI for CML and Options Upon Progression

Fadi Haddad, MDGabriela Hobbs, MDRahul Gosain, MD, MBARohit Gosain, MD
Advanced medical professionals discussing evolving treatment options for therapy-related and de novo AML in hematology research.

Challenging cases

02/11/2026

Challenging Cases: The Evolving Treatment Landscape for Therapy-Related and De Novo AML

Naval Daver, MDRahul Gosain, MD, MBARohit Gosain, MD
1. Expert panel discussing diagnosis and treatment of anemia and iron overload in cancer patients at OncUpdates conference.

Challenging cases

12/07/2025

Challenging Cases: Diagnosis and Treatment of Anemia or Iron Overload

Marina Beltrami-Moreira, MDRahul Gosain, MD, MBARohit Gosain, MD
Because I can't access external links or view images, I can't analyze the specific image from the URL provided. However, based on the description and context related to "OncUpdates" and the title "Selecting Treatments for Cases in Relapsed or Refractory RCC," I can generate SEO-optimized text for a typical promotional or informational medical image related to this topic.

Challenging cases

12/05/2025

Selecting Treatments for Cases in Relapsed or Refractory RCC

David Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Deep learning models for thrombocytopenia management with Dr. Ronak Mistry, Dr. Rahul Gosain, and Dr. Rohit Gosain, focusing on practical lessons for clinicians in hematology and patient care.

Challenging cases

12/02/2025

Thrombocytopenia Management: Practical Lessons For Clinicians

Ronak Mistry, DORahul Gosain, MD, MBARohit Gosain, MD
An SEO-friendly ALT tag:.

Challenging cases

11/26/2025

Discussing Challenging Cases in NMIBC

Joshua Meeks, MD, PhDShilpa Gupta, MDRohit Gosain, MDRahul Gosain, MD, MBA
An informative graphic featuring Dr. Sara Tolaney, Dr. Adam Brufsky, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing the use of CDK4/6 inhibitors in HR+ breast cancer cases.

Challenging cases

11/24/2025

Assessing CDK4/6 Inhibitor Use in HR+ Breast Cancer Cases

Sara Tolaney, MD, MPHAdam Brufsky, MD, PhDRohit Gosain, MDRahul Gosain, MD, MBA
An informative medical panel discussion on venous thromboembolism (VTE) featuring Dr. Jennifer Vaughn, Dr. Nicolas Gallastegui Crestani, Dr. Rahul Gosain, and Dr. Rohit Gosain, focusing on challenging.

Challenging cases

11/08/2025

Clinical Decision-Making in Unprovoked vs Provoked Pulmonary Embolism

Jennifer Vaughn, MDNicolas Gallastegui Crestani, MDRahul Gosain, MD, MBARohit Gosain, MD
Eric Singhi

Challenging cases

10/20/2025

Treating Complex Cases of EGFR-Mutated NSCLC

Eric Singhi, MDRahul Gosain, MD, MBARohit Gosain, MD
Overcoming challenges in relapsed or refractory FLT3-positive AML featuring Dr. Uma Borate, Dr. Navali Daver, Dr. Rohit Gosain, and Dr. Rahul Gosain, discussing innovative approaches in hematology and oncology.

Challenging cases

07/29/2025

Overcoming Challenges in Relapsed or Refractory FLT3-Positive AML

Naval Daver, MDRahul Gosain, MD, MBARohit Gosain, MDUma Borate, MBBS
Bioscientists discussing targeted bispecific antibody therapies in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) at OncUpdates conference.

Challenging cases

07/22/2025

Selecting Bispecific Antibody Therapies in RR DLBCL

Carla Casulo, MDTara Graff, DO, MS

New Approvals

View All
Dr. Sara Tolaney, Dr. Rahul Gosain, and Dr. Rohit Gosain discuss new indications for Sacituzumab Govitecan in TNBC.

New Approvals

07/13/2026

ASCENT-03 and ASCENT-04 Lead to New Indications for Sacituzumab Govitecan in TNBC

Sara Tolaney, MD, MPHRahul Gosain, MD, MBARohit Gosain, MD
Dr. Scott Kopetz discusses a new treatment option for metastatic colorectal cancer with BRAF V600E mutation, featuring experts Dr. Rahul Gosain and Dr. Rohit Gosain.

New Approvals

04/30/2026

BREAKWATER: New Treatment Option for Metastatic Colorectal Cancer With BRAF V600E Mutation

Scott Kopetz, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Dr. Luciano Costa, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing approved treatments for relapsed multiple myeloma, highlighting recent advances in oncology research.

New Approvals

03/10/2026

Teclistamab Plus Daratumumab Approved for Relapsed or Refractory Multiple Myeloma After MajesTEC-3

Luciano Costa, MDRahul Gosain, MD, MBARohit Gosain, MD
Expert panel discussing clinical implications of Enfortumab Vedotin plus Pembrolizumab in cisplatin-ineligible metastatic bladder cancer at OncUpdates.

New Approvals

03/03/2026

Transformative Data in Cisplatin-Ineligible MIBC: Clinical Implications of Enfortumab Vedotin Plus Pembrolizumab

Thomas Powles, MD, MBBS, MRCPRahul Gosain, MD, MBARohit Gosain, MD
Expert discussion on IL-15 therapy in cancer care featuring Dr. Patrick Soon-Shiong, Dr. Rahul Gosain, and Dr. Rohit Gosain at OncUpdates.

New Approvals

02/25/2026

The Promise of Anktiva: Expert Insight on IL-15 Therapy in Cancer Care

Patrick Soon-Shiong, MDRahul Gosain, MD, MBARohit Gosain, MD
Quality image showing Dr. Vincent Rajkumar, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing Aquila Trial Insights on Daratumumab for high-risk smoldering myeloma treatment, featured on OncUpdates.

New Approvals

02/21/2026

AQUILA Trial Insights: Daratumumab for the Treatment of High-Risk Smoldering Myeloma

S. Vincent Rajkumar, MDRahul Gosain, MD, MBARohit Gosain, MD
Enhanced breast cancer research presentation featuring Dr. Sara Tolaney, Dr. Rahul Gosain, and Dr. Rohit Gosain discussing T-DXd Plus Pertuzumab and new data in HER2+ metastatic breast cancer.

New Approvals

02/18/2026

T-DXd Plus Pertuzumab and New Data in HER2+ Metastatic Breast Cancer

Sara Tolaney, MD, MPHRohit Gosain, MDRahul Gosain, MD, MBA
EPCORE FL-1 trial discussing Epcoritamab, Lenalidomide, and Rituximab for follicular lymphoma, featuring Dr. Giles Salles, Dr. Rahul Gosain, and Dr. Rohit Gosain, highlighting advancements in lymphoma treatment and research.

New Approvals

12/04/2025

EPCORE FL-1: Epcoritamab Plus Lenalidomide and Rituximab for Follicular Lymphoma

Gilles Salles, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
1. Durvalumab approved for resectable upper gastrointestinal cancers with expert oncologists discussing treatment options.

New Approvals

12/03/2025

Durvalumab Approved For Resectable Upper Gastrointestinal Cancers

Yelena Janjigian, MDRahul Gosain, MD, MBARohit Gosain, MD
KOMET-001 approval, Ziftomenib, NPM1-mutated AML, new cancer treatment, oncological breakthrough, OncUpdates featured.

New Approvals

11/19/2025

KOMET-001 Leads to Ziftomenib Approval for NPM1-Mutated AML

Eunice Wang, MDRahul Gosain, MD, MBARohit Gosain, MD
FDA approval of Zongertinib in HER2-mutated NSCLC for targeted cancer treatment.

New Approvals

08/25/2025

FDA Approval of Zongertinib in HER2-Mutated NSCLC

Joshua Sabari, MDRahul Gosain, MD, MBARohit Gosain, MD
FDA approves Dato-DXd for EGFR-mutated NSCLC patients - latest oncology update from OncUpdates.

New Approvals

08/18/2025

FDA Approves Dato-DXd for Patients With EGFR-Mutated NSCLC

Jacob Sands, MDRahul Gosain, MD, MBARohit Gosain, MD

New Approvals

05/16/2025

FDA Approval of Cabozantinib in Neuroendocrine Tumors

Aman Chauhan, MD
Perioperative Durvalumab FDA approval for muscle invasive bladder cancer, OncUpdates news.

New Approvals

05/16/2025

Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

Thomas Powles, MD, MBBS, MRCP

Tox Check

View All
Group photo of three medical professionals discussing BRAF and MEK inhibitor side effects in NSCLC, featuring Dr. Melissa Johnson, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Tox Check

05/28/2026

BRAF and MEK Inhibitor Side Effects in BRAF V600E–Mutated NSCLC

Melissa Johnson, MDRahul Gosain, MD, MBARohit Gosain, MD
Experts discussing targeted therapy strategies for managing toxicities in multiple myeloma treatment, featuring Dr. Hamza Hashmi, Dr. Cesar Rodriguez, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Tox Check

05/20/2026

Bispecific Therapy in Multiple Myeloma: Strategies for Managing Toxicities

Hamza Hashmi, MDCesar Rodriguez, MDRahul Gosain, MD, MBARohit Gosain, MD
Expert discussion on managing side effects of EGFR inhibitors in non-small cell lung cancer (NSCLC) with Dr. Azam Farooqi, Dr. Joshua Sabari, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Tox Check

05/18/2026

How To Manage Side Effects of EGFR Inhibitors in NSCLC

Azam Farooqui, MDJoshua Sabari, MDRahul Gosain, MD, MBARohit Gosain, MD
Expert guidance on managing side effects of colorectal cancer therapies, featuring Dr. Rona Yaeger and colleagues, for improved patient care and treatment outcomes.

Tox Check

05/06/2026

How to Manage Side Effects of Colorectal Cancer Therapies

Rona Yaeger, MDRahul Gosain, MD, MBARohit Gosain, MD
Toxicity check for PI3K/AKT inhibitor side effects in metastatic breast cancer with experts Dr. Emily Gallagher and Dr. Neil Iyengar.

Tox Check

01/06/2026

PI3K/AKT Inhibitor Side Effect Management in Metastatic Breast Cancer

Emily Gallagher, MD, PhDNeil Iyengar, MDRohit Gosain, MDRahul Gosain, MD, MBA
Toxicity awareness in novel antibody-drug conjugates and NSCLC, featuring expert insights from Dr. Jacob Sands, Dr. Rohit Gosain, and Dr. Rahul Gosain on key adverse effects and safety considerations.

Tox Check

01/02/2026

Key Adverse Effects of Novel Antibody-Drug Conjugates in NSCLC

Jacob Sands, MDRahul Gosain, MD, MBARohit Gosain, MD
Optimizing ROS1 inhibitor therapy in NSCLC with insights from Dr. Estelamari Rodriguez and colleagues for cancer research and targeted lung cancer treatment.

Tox Check

11/15/2025

Optimizing ROS1 Inhibitor Therapy in NSCLC

Estelamari Rodriguez, MD, MPHRohit Gosain, MDRahul Gosain, MD, MBA
Toxicity management in cancer treatment, featuring experts Dr. Fadi Haddad, Dr. Onyee Chan, Dr. Rahul Gosain, and Dr. Rohit Gosain, discussing side effects of Tyrosine Kinase Inhibitors in CML.

Tox Check

11/11/2025

How to Manage Side Effects of Tyrosine Kinase Inhibitors in CML

Fadi Haddad, MDOnyee Chan, MDRahul Gosain, MD, MBARohit Gosain, MD
Advanced breast cancer research discussion featuring Dr. Stephanie Graff, Dr. Rohit Gosain, and Dr. Rahul Gosain on managing side effects of CDK4/6 inhibitors.

Tox Check

10/16/2025

Managing Side Effects of CDK4/6 Inhibitors in Breast Cancer

Stephanie Graff, MD, FACP, FASCORahul Gosain, MD, MBARohit Gosain, MD
Strategies to Minimize Side Effects in RCC Treatment for Oncology Professionals - OncUpdates.

Tox Check

08/07/2025

Strategies to Minimize Side Effects in RCC Treatment

Sumanta Pal, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD
Managing side effects of anti-VEGF Bevacizumab and anti-EGFR Cetuximab and Panitumumab in cancer treatment, presented by OncUpdates.

Tox Check

05/28/2025

Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

Pashtoon Kasi, MD, MS
Managing side effects of pancreatic cancer treatment with expert insights from oncologists and latest research updates on ToxCheck.

Tox Check

05/28/2025

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

Midhun Malla, MDRachna Shroff, MD, MS, FASCO

Tox Check

05/28/2025

How to Manage Anti-EGFR Toxicities in NSCLC

Gilberto Lopes, MD
TOX CHECK - Safety Profile of CAR-T Therapy, Managing Side Effects of CAR-T, Cancer Immunotherapy, Oncology Updates from OncUpdates platform.

Tox Check

05/16/2025

CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy

Jason Westin, MD, MS, FASCOSurbhi Sidana, MD

Resource Centers

View All
Overview of CAR T-cell therapy and bispecific antibodies for relapsed or refractory multiple myeloma with real-world sequencing insights.

Resource Centers

07/14/2026

CAR T or Bispecific Antibodies First? Real-World Sequencing Insights in Relapsed/Refractory Multiple Myeloma

Sawyer Bawek, DO
CAR T-cell therapy in multiple myeloma with insights from ASCO 2026, featuring experts Dr. Binod Dhakal, Dr. Surbhi Sidana, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Ajai Chari.

Resource Centers

06/27/2026

CAR T in Myeloma: Earlier Use and Sequencing Insights from ASCO 2026

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Two medical professionals, a woman and a man, in white coats with a city skyline background, discussing RAS-targeted therapy in pancreatic adenocarcinoma.

Resource Centers

06/19/2026

Daraxonrasib and the Future of RAS Inhibitors in Pancreatic Cancer

Antonella Cammarota, PhDMichael May, MD
Panel discussion on managing toxicity and expanding RAS therapy in pancreatic cancer featuring Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, and Dr. Shu.

Resource Centers

06/16/2026

Managing Toxicity and Expanding RAS Therapy in Pancreatic Cancer

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Panel of oncology experts discussing the clinical impact of RASolution 302 in doubling patient survival.

Resource Centers

06/15/2026

Doubling Survival: The Clinical Impact of RASolute 302

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Panel discussion on drug development and clinical success in RAS-driven cancer, featuring experts Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, and Dr.

Resource Centers

06/14/2026

From Drug Design to Phase 3 Success in RAS-Driven Disease

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBA
Dr. Andrew H. Ko, Dr. Eileen O'Reilly, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Rachna Shroff, Dr. Shubham Panti discuss Daraxonrasib's impact on pancreatic cancer survival.

Resource Centers

06/13/2026

Daraxonrasib Delivers Breakthrough Survival Gains in Pancreatic Cancer

Andrew H. Ko, MDEileen O'Reilly, MDShubham Pant, MD, MBBSRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Group of medical professionals discussing real-world safety and care coordination for CAR T-cell therapy, featuring Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Surbhi Sidana, Dr. Ajai Chari, and Dr. Binod.

Resource Centers

06/12/2026

Multiple Myeloma Experts Highlight Real-World Safety and Care Coordination Following CAR T-Cell Therapy

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of multiple myeloma experts discussing CAR T and BCMA therapies, including Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Surbhi Sidana, Dr. Binod Dhakal, and Dr. Ajai Chari, during a virtual conferenc.

Resource Centers

06/11/2026

CAR T vs BCMA-Directed Bispecific Antibodies: Multiple Myeloma Experts Share Sequencing Insights

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Innovative CAR T-cell therapy for relapsed or refractory multiple myeloma, featuring expert insights from Dr. Surbhi Sidana, Dr. Rahul Gosain, Dr. Ajai Chari, and Dr. Binod Dhakal.

Resource Centers

06/10/2026

CAR T-Cell Therapy Moves Earlier in Relapsed/Refractory Multiple Myeloma

Ajai Chari, MDBinod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Two medical professionals, Dr. Rohit Gosain and Dr. Danai Dima, discuss CAR-T therapy for multiple myeloma in an urban cityscape background.

Resource Centers

06/08/2026

How Community Oncologists Can Optimize CAR T-Cell Therapy for Patients With Multiple Myeloma

Danai Dima, MDRohit Gosain, MD
Experts Dr. Rohit Gosain and Dr. Samer Al Hadidi discuss follow-up data on CAR T cell therapy safety and effectiveness in high-risk multiple myeloma patients.

Resource Centers

06/05/2026

ASCO 2026 Follow-Up Data Support CAR T Safety and Activity in High-Risk Multiple Myeloma

Samer Al Hadidi, MDRohit Gosain, MD
Close-up of Verenzo (bevemacil) 50 mg tablets in packaging, used for erectile dysfunction treatment, displayed on a white background.

Resource Centers

06/05/2026

CAR T in Myeloma: Earlier Use and Sequencing Insights from ASCO 2026

Binod Dhakal, MDSurbhi Sidana, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of medical experts discussing the impact of RASolute 302 on clinical practice for metastatic pancreatic ductal adenocarcinoma (PDAC).

Resource Centers

06/02/2026

Clinical Insights: Impact of RASolute 302 on Clinical Practice in Previously Treated Metastatic PDAC

Andrew H. Ko, MDShubham Pant, MD, MBBSEileen O'Reilly, MDRachna Shroff, MD, MS, FASCORahul Gosain, MD, MBARohit Gosain, MD
Advanced medical professionals discussing treatment considerations and safety updates in metastatic pancreatic adenocarcinoma, with a cityscape background emphasizing healthcare expertise and research.

Resource Centers

03/10/2026

Treatment Considerations and Safety Updates in Metastatic Pancreatic Adenocarcinoma

Rahul Gosain, MD, MBARohit Gosain, MD
Advances in pancreatic and biliary tract cancers at ASCO GI 2026, expert insights, oncology research, cancer treatment innovations, medical conference, OncUpdates.

Resource Centers

02/08/2026

Advances in Pancreatic and Biliary Tract Cancers at ASCO GI 2026: Expert Insights

Anupriya Singhal, MD, PhD
1. Emerging targeted and combination strategies in pancreatic cancer for improved treatment outcomes, featuring experts Angelo Pirozzi, MD, and Fiyinfolu Balogun, MD, PhD, against San Francisco skyline backdrop.

Resource Centers

01/23/2026

Pancreatic Cancer Highlights From ASCO GI 2026

Fiyinfolu Balogun, MD, PhDAngelo Pirozzi, MD
N/A.

Resource Centers

01/20/2026

Optimal Frontline Treatment in Metastatic Pancreatic Cancer

Raji Shameem, MDRohit Gosain, MD
KRAS inhibitors, targeted therapy, GI oncology, cancer treatment, molecular targeted therapy, cancer research, precision medicine, oncology advancements, clinical oncology, cancer therapy innovation.

Resource Centers

01/19/2026

Molecular Profiling Expands Treatment Options in Pancreatic and Biliary Tract Cancers

Dina Ioffe, MDShubham Pant, MD, MBBS
Pink breast cancer awareness ribbon held by woman, health awareness, oncology, cancer support, breast cancer prevention, oncology updates, cancer awareness campaign, breast cancer research, cancer survivor advocacy.

Resource Centers

01/14/2026

Best Practices for Initiating CDK4/6 Inhibitor Therapy in HR+Metastatic Breast Cancer

Arya Mariam Roy, MD
Inflammation in the pancreas indicating pancreatic cancer, with an anatomical focus on the abdomen, digital medical illustration, highlighting key areas associated with pancreatic tumors and gastrointestinal health.

Resource Centers

01/07/2026

Pancreatic Cancer in 2025: Nearing an Inflection Point

Udhayvir Singh Grewal, MD
Immune cells attacking cancer cells, cancer immunotherapy, tumor microenvironment, oncology research, blood vessel interaction, cancer treatment strategies, immunology, medical imaging for cancer diagnostics.

Resource Centers

12/26/2025

Year in Review: The Rise of Cellular Immunotherapy for Multiple Myeloma

Hamza Hashmi, MD
Adjuvant CDK4/6 inhibition in early breast cancer discussed by renowned experts Matthew Kurian and Komal Jhaveri at OncUpdates.

Resource Centers

12/21/2025

NATALEE and Other Updates for HR+ Early Breast Cancer at SABCS 2025

Komal Jhaveri, MD, FACPMatthew Kurian, MD
1. OncUpdates logo with medical professionals discussing novel therapies for HER2-positive and triple-negative breast cancer.

Resource Centers

12/19/2025

Evolving Treatment Paradigms in Advanced Breast Cancer: Key Trial Updates From SABCS 2025

Karissa Britten, MDVaishali Deenadayalan, MD
1. Advances in early-stage breast cancer treatment focusing on CDK4/6 inhibitors for adjuvant therapy.

Resource Centers

12/19/2025

Key Insights From the NATALEE Trial 

Karissa Britten, MDMatthew Kurian, MD
High magnification image of cancerous tissue stained with H&E, showing tumor cells and surrounding stroma, relevant for oncology research and cancer diagnosis.

Resource Centers

12/02/2025

Comparative Safety of CDK4/6 Inhibitors: Key AEs and Management Approaches

Jasmin Hundal, MD
Breast cancer awareness, woman holding her chest, health precautions, self-exam for early detection, medical health, oncology, cancer prevention, healthcare tips.

Resource Centers

12/01/2025

The Evolving Role of Ribociclib and Optimizing First-Line Treatment in HR+/HER2- Metastatic Breast Cancer 

Nerea Lopetegui-Lia, MD
Expert medical professionals discuss cancer treatment advances at an oncology conference, emphasizing personalized medicine and innovative research in cancer care.

Resource Centers

06/10/2025

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

Seyi Abidoye, MBBSLisa Liu, MD
Managing side effects of pancreatic cancer treatment with expert insights from oncologists and latest research updates on ToxCheck.

Resource Centers

05/28/2025

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

Midhun Malla, MDRachna Shroff, MD, MS, FASCO

Articles

View All
Overview of CAR T-cell therapy and bispecific antibodies for relapsed or refractory multiple myeloma with real-world sequencing insights.

Article

07/14/2026

CAR T or Bispecific Antibodies First? Real-World Sequencing Insights in Relapsed/Refractory Multiple Myeloma

Sawyer Bawek, DO
Presentation slide showing SARC041 study on CDK4/6 inhibition as a treatment for dedifferentiated liposarcoma with modern cityscape background.

Article

06/29/2026

SARC041: Establishing CDK4/6 Inhibition as a New Treatment Option in Dedifferentiated Liposarcoma

Samantha Armstrong, MD
Microscopic view of blood cells showing leukemia, highlighting Ziftomenib Plus induction for AML treatment.

Article

06/24/2026

EHA 2026: Ziftomenib Plus Intensive Induction Shows Deep Durable Responses in Newly Diagnosed NPM1-Mutant or KMT2A-Rearranged AML

Sawyer Bawek, DO
City street scene with theater marquee and skyscrapers, highlighting recent advances in GU cancers from ASCO 2026.

Article

06/19/2026

Practice-Changing Shifts in GU Cancers From ASCO 2026

Jesus Gomez, MDManas Pustake, MD
Cityscape with river and skyscrapers, highlighting new cancer treatment developments in head and neck cancer research.

Article

06/17/2026

From Resistance to Response: Amivantamab Opens a New Chapter in Head and Neck Cancer

Coral Olazagasti, MD
City skyline with water and text about GU experts on bladder, kidney, and prostate cancer trials.

Article

06/17/2026

GU Experts Weigh In on Trials That Could Redefine Bladder, Kidney, and Prostate Cancer Care

Andre Kydd, MD, PhD
Image showing the ASCO 2026 conference banner with the study title on a city skyline background, highlighting advancements in multiple myeloma treatment.

Article

06/16/2026

ASCO 2026: Mezigdomide Plus Kd Doubles PFS in Heavily Pretreated Multiple Myeloma in SUCCESSOR-2

Sawyer Bawek, DO
Aerial view of New York City skyline with river and park, highlighting advancements in pancreatic cancer treatment.

Article

06/15/2026

Daraxonrasib Delivers Game-Changing Survival Benefit in Previously Treated PDAC

Sunnie Kim, MD
Visual representation of integrating circulating tumor DNA (ctDNA) into muscle-invasive bladder cancer treatment strategies, with a city skyline background.

Article

06/14/2026

Integrating ctDNA Into Muscle-Invasive Bladder Cancer Treatment

Miles Hsu, MD
Insights from ASCO 2026 on antibody-drug conjugates reshaping metastatic triple-negative breast cancer treatment.

Article

06/14/2026

Insights from ASCO 2026: Antibody–Drug Conjugates Continue to Reshape Metastatic Triple-Negative Breast Cancer

Stephanie Haddad, DO
Overview of GLP-1 receptor agonists and their role in breast cancer treatment, featuring insights from Cleveland Clinic expert Jasmin Hundal, MD, MS, MPH.

Article

06/11/2026

GLP-1 Receptor Agonists in Breast Cancer: Moving Beyond Weight Loss Toward Cancer Prevention and Survivorship

Jasmin Hundal, MD
ASCO 2026 presentation on Giredestrant for ER+/HER2- metastatic breast cancer at Roswell Park Cancer Center.

Article

06/10/2026

ASCO 2026: Evaluating Giredestrant in First-Line ER+/HER2- Metastatic Breast Cancer

Vaishali Deenadayalan, MD
Key ASCO 2026 updates on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) presented at OncUpdates, highlighting recent advancements and research findings.

Article

06/09/2026

Key ASCO 2026 Updates in NSCLC and SCLC

Chinmay Jani, MDTessa Lavorgna, MD
Aerial view of a city skyline with a waterfront, highlighting the latest insights from ASCO 2026 on evolving treatment strategies for gastrointestinal cancers.

Article

06/07/2026

Insights From ASCO 2026: Evolving Treatment Strategies in Gastrointestinal Malignancies

Aslihan Yerlikaya, MD
Clinical trial image showing Broke Kania, DO, discussing the Talaporo-3 study on cancer treatment with Talazoparib and Enzalutamide for HRR-mutated mCSPC.

Article

06/06/2026

TALAPRO-3: A Major rPFS Win in HRR-Mutated mCSPC, But Which Patients Benefit Most?

Brooke Kania, DO
Overview of the Episode III clinical trial showing aspirin's lack of DFS benefit in stage III colorectal cancer, with a cityscape background.

Article

06/05/2026

EPISODE-III Trial: Adjuvant Aspirin Shows No DFS Benefit in Stage III CRC

Young Rho, MD
Overview of six key breast cancer clinical trials presented at ASCO 2026, highlighting advancements in breast cancer treatment and research.

Article

06/04/2026

Six Practice-Informing Breast Cancer Trials From ASCO 2026

Nerea Lopetegui-Lia, MD
Overview of EV-302 update on enfortumab vedotin and pembrolizumab improving survival in metastatic urothelial cancer patients.

Article

06/03/2026

EV-302 Update: Enfortumab Vedotin Plus Pembrolizumab Maintains Survival Benefit at 3.5 Years in Metastatic Urothelial Cancer

Saad Atiq, MD
Overview of thoracic oncology highlights at ASCO 2026, focusing on lung cancer research and treatment updates for oncologists and medical professionals.

Article

05/28/2026

What to Watch at ASCO 2026: A Thoracic Oncologist’s Guide to the Lung Cancer Program

Dan Morgenstern, MDChinmay Jani, MDGilberto Lopes, MD
Teclistamab monotherapy shown as a promising treatment for multiple myeloma, highlighting survival benefits in early relapsed or refractory cases.

Article

05/27/2026

MajesTEC-9: Teclistamab Monotherapy Delivers Survival Benefits in Early Relapsed/Refractory Multiple Myeloma

Sawyer Bawek, DO
Medical illustration showing cancer cells and immune response, emphasizing post-IO strategy in metastatic renal cell carcinoma (mRCC) and the role of TKI therapy timing.

Article

05/27/2026

Refining the Post-IO Strategy in mRCC: The Role of TKIs and the Nuance of Timing

Karan Jatwani, MDUrvi Patel, DO, MPH
Medical professional performing a laboratory test related to NSCLC treatment research, highlighting advanced oncology diagnostics and targeted therapies.

Article

05/18/2026

Beyond Osimertinib Monotherapy: Frontline Intensification in EGFR-Mutant NSCLC After FLAURA2 and MARIPOSA

Chinmay Jani, MDRuchi JaniGilberto Lopes, MD
Modern metallic sculpture in an urban setting with skyscrapers, promoting the ASCO 2026 gastrointestinal cancer conference and research updates.

Article

05/15/2026

ASCO 2026: Gastrointestinal Abstracts to Watch

Raji Shameem, MD
Medical professional holding a stethoscope, focusing on the evolving landscape of refractory renal cell carcinoma in cancer treatment.

Article

05/14/2026

The Evolving Landscape of Refractory Renal Cell Carcinoma 

Michael Serzan, MD
Overview of targeted therapies following immunotherapy in metastatic renal cell carcinoma, highlighting treatment strategies and clinical insights.

Article

05/13/2026

TKIs After Upfront Immunotherapy in Metastatic RCC: A Practical Review

Brendan Guercio, MD
Oncology Brothers moderating third annual Upstate Cancer Symposium for community clinical practice, focusing on latest oncology research and patient care.

Article

05/05/2026

Oncology Brothers to Moderate Third Annual Upstate Cancer Symposium for Community Clinical Practice

Kaylee Giacomini, MPH
SignifyMD partners with leading oncology voices to host two live events during ASCO annual meeting, highlighting advancements in cancer care and oncology research.

Article

05/01/2026

SignifyMD Partners With Leading Oncology Voices to Host Two Live Events During ASCO Annual Meeting

Kaylee Giacomini, MPH
Bladder, prostate, and kidney cancer updates from ASCO GU 2026, featuring medical professionals discussing recent advancements in cancer treatment and research.

Article

03/20/2026

ASCO GU 2026: Key Updates in Bladder, Prostate, and Kidney Cancer

Charbel Matar, MD
ASCO GU 2026 conference banner highlighting novel therapies transforming genitourinary oncology, featuring the Golden Gate Bridge in San Francisco.

Article

03/13/2026

ASCO GU 2026: Novel Therapies Transform Genitourinary Oncology

Manas Pustake, MD
Evolving treatment strategies in bladder cancer research presented by OncUpdates, featuring medical professionals discussing innovative therapies and recent advancements in bladder cancer management.

Article

03/09/2026

Insights from ASCO GU 2026: Evolving Treatment Strategies in Bladder Cancer

Zeynep Irem Ozay, MD
Evolving standards in renal cell carcinoma research and treatment, with practical insights for healthcare professionals and oncologists.

Article

03/05/2026

Evolving Standards in Renal Cell Carcinoma: Practical Insights from ASCO GU

Adriana Penate, MD
Advanced visualization of immune cells and cancerous cells related to multiple myeloma, highlighting emerging treatment strategies and expert insights.

Article

02/19/2026

Expert Insight on Emerging Strategies in Multiple Myeloma

Mehndi Dandwani, MD
Advanced research on gastrointestinal cancers highlighting biomarker-driven therapies for CRC and NETs, featuring expert insights from Deepak Vadehra, DO, at Roswell Park Comprehensive Cancer Center.

Article

02/12/2026

Gastrointestinal Cancers: Biomarker-Driven Advances in CRC and NETs

Deepak Vadehra, DO
Advances in pancreatic and biliary tract cancers at ASCO GI 2026, expert insights, oncology research, cancer treatment innovations, medical conference, OncUpdates.

Article

02/08/2026

Advances in Pancreatic and Biliary Tract Cancers at ASCO GI 2026: Expert Insights

Anupriya Singhal, MD, PhD
1. Doctor explaining lung cancer scan results to patient with lung model and medical images on computer screen, in a clinical setting.

Article

01/25/2026

Top Lung Cancer Advances From 2025

Chinmay Jani, MDAli Al Sbihi, MDGilberto Lopes, MD
CT22-01-2023 - Medical professional analyzing upper gastrointestinal cancer research updates at Roswell Park, highlighting practice-changing advances in diagnosis and treatment.

Article

01/23/2026

Practice-Changing Updates in Upper Gastrointestinal Cancers From ASCO GI 2026

Vaishali Deenadayalan, MD
1. Hands holding a pink ribbon symbolizing breast cancer awareness on a gray background.

Article

01/17/2026

From ADCs to Oral SERDs: Practice-Changing Insights from SABCS 2025

Zunairah Shah, MD
Pink breast cancer awareness ribbon held by woman, health awareness, oncology, cancer support, breast cancer prevention, oncology updates, cancer awareness campaign, breast cancer research, cancer survivor advocacy.

Article

01/14/2026

Best Practices for Initiating CDK4/6 Inhibitor Therapy in HR+Metastatic Breast Cancer

Arya Mariam Roy, MD
Blood sample in a test tube with laboratory report background, highlighting hematology and oncology research.

Article

01/11/2026

Key Studies Shaping Hematology, Community Oncology at ASH 2025

Sawyer Bawek, DO
Inflammation in the pancreas indicating pancreatic cancer, with an anatomical focus on the abdomen, digital medical illustration, highlighting key areas associated with pancreatic tumors and gastrointestinal health.

Article

01/07/2026

Pancreatic Cancer in 2025: Nearing an Inflection Point

Udhayvir Singh Grewal, MD
Enhanced medical research on hematology and oncology at ASH 2025 conference with clinical laboratory professionals.

Article

01/07/2026

ASH 2025 Breakthroughs: Key Studies Shaping Hematology and Community Oncology

Sawyer Bawek, DO
HER2-positive breast cancer updates from SABCS 2023, featuring expert Vaishali Deenadayalan at Roswell Park, emphasizing advancements in treatment and research in oncology for improved patient outcomes.

Article

12/30/2025

Updates in HER2-Positive Breast Cancer From SABCS 2025

Vaishali Deenadayalan, MD
Innovative hormone receptor-positive breast cancer treatment paradigms discussed by Dr. Jasmin Hundal, expert from Cleveland Clinic, highlighting advancements and research updates in oncology.

Article

12/27/2025

Shifting Treatment Paradigms in Hormone Receptor–Positive Breast Cancer 

Jasmin Hundal, MD
Immune cells attacking cancer cells, cancer immunotherapy, tumor microenvironment, oncology research, blood vessel interaction, cancer treatment strategies, immunology, medical imaging for cancer diagnostics.

Article

12/26/2025

Year in Review: The Rise of Cellular Immunotherapy for Multiple Myeloma

Hamza Hashmi, MD
1. Advanced blood cancer cells including leukemia, lymphoma, myeloma, and chronic lymphocytic leukemia (CLL).

Article

12/24/2025

CLL, AML, Lymphoma, and Myeloma Updates Poised to Impact Clinical Practice

Valentina Ardila Avila, MD
Enhanced leukemia research and advancements discussed at ASH 2025, offering expert insights and future directions in hematologic cancer treatment from renowned specialists.

Article

12/23/2025

Leukemia Advances at ASH 2025: Expert Insights and Future Directions

Niranjan Khaire, MBBS, MD, DM
Advanced personalized chemotherapy strategies for chronic lymphocytic leukemia based on ASH 2025 guidelines. Expert insights by Lauren M. Granat, DO, MS, on targeted cancer therapies.

Article

12/22/2025

ASH 2025 Signals Shift Toward Personalized, Time-Limited Therapy in Chronic Lymphocytic Leukemia

Lauren M. Granat, DO, MS
Advances in early-stage and metastatic triple-negative breast cancer (TNBC) treatments, featuring expert insights from Dr. Briana To, highlighting evolving oncologic approaches and clinical research.

Article

12/19/2025

Evolving Approaches to Early-Stage and Metastatic TNBC

Briana To, DO, PhD
1. New research data on lymphoma care presented at ASH 2025, emphasizing advances from frontline treatment to relapse management.

Article

12/14/2025

New Data at ASH 2025 Reshapes Lymphoma Care From Frontline to Relapsed Disease

Rafaella Litvin, MD
High magnification image of cancerous tissue stained with H&E, showing tumor cells and surrounding stroma, relevant for oncology research and cancer diagnosis.

Article

12/02/2025

Comparative Safety of CDK4/6 Inhibitors: Key AEs and Management Approaches

Jasmin Hundal, MD
Breast cancer awareness, woman holding her chest, health precautions, self-exam for early detection, medical health, oncology, cancer prevention, healthcare tips.

Article

12/01/2025

The Evolving Role of Ribociclib and Optimizing First-Line Treatment in HR+/HER2- Metastatic Breast Cancer 

Nerea Lopetegui-Lia, MD
1. Medical professional analyzing lung cancer CT scan highlighting tumor with red laser pointer, illustrating cancer diagnosis and screening.

Article

11/25/2025

Revolutionizing Treatment for EGFR-Mutated NSCLC

Coral Olazagasti, MD
Chest X-ray showing lung cancer, medical diagnosis, healthcare, oncology scan, doctor reviewing cancer imaging.

Article

11/18/2025

Ivonescimab Plus Chemotherapy in EGFR+ NSCLC After TKI Therapy

Ali Al Sbihi, MDChinmay Jani, MD
Malignant tumor in the lung with cancerous growth and tumor cells, medical illustration of lung cancer pathology for oncology and cancer research.

Article

11/17/2025

Dual Targeting: Iza-bren Shows Promising Early Results Across Solid Tumors

Samantha El Warrak, MBBSChinmay Jani, MD
Lung cancer with tumor showing cancerous growth affecting the bronchi and surrounding lung tissue, emphasizing medical research and oncology treatment.

Article

11/14/2025

PALOMA-2: Subcutaneous Amivantamab Plus Lazertinib Delivers MARIPOSA-Level Efficacy with Improved Safety

Akshee Batra, MDChinmay Jani, MD
Innovative targeted antibody-drug conjugate for relapsed small cell lung cancer (SCLC) at WCLC 2025. Focus on recent developments in cancer immunotherapy and targeted treatments for lung cancer patients.

Article

11/13/2025

DLL3-Targeted Antibody-Drug Conjugate Reignites Hope for Relapsed SCLC

Asad Rauf, MDChinmay Jani, MDAman Chauhan, MD
CT scan of a chest showing lung health, used in cancer diagnosis and treatment monitoring.

Article

11/12/2025

Chemotherapy Plus Osimertinib Offers Overall Survival Benefit in EGFR-mutated NSCLC

Daniel Tuerff, MDChinmay Jani, MDEstelamari Rodriguez, MD, MPH
ESMO 2025 conference banner highlighting updates in HR+ metastatic breast cancer landscape, with a historic building in the background.

Article

11/10/2025

ESMO 2025: Updates in the HR+ Metastatic Breast Cancer Landscape 

Sarah Premji, MDKarthik Giridhar, MD
PSA test blood sample for prostate cancer detection in laboratory setting.

Article

11/06/2025

ESMO 2025 Updates in Prostate Cancer: Advances in Radioligand, Genomic, and AR-Targeted Therapies

Michael Serzan, MD
Berlin Museum Island with historical architecture and river view during sunset, featuring a boat cruising on the Spree River, with modern Berlin skyline in the background.

Article

10/29/2025

ESMO 2025: Updates in Bladder Cancer

Vishesh Khanna, MD
Electronic health records consultation with healthcare professional discussing cancer treatment options.

Article

10/28/2025

ESMO 2025 Breaking New Ground in Breast Cancer: Five Trials to Know

Matthew Kurian, MD
Vibrant scientific laboratory scene with test tubes and a pipette, showcasing advanced cancer research and clinical trials, highlighting oncology innovations and medical breakthroughs in cancer treatment.

Article

10/25/2025

ESMO 2025: Updated Results From the monarchE Trial in Early Breast Cancer

Sarah Premji, MDMatthew Goetz, MD
Microscopic view of cancer cells, illustrating cellular structures and tumor development for oncology research and cancer treatment insights.

Article

10/24/2025

Key Updates in Gastrointestinal Oncology from ESMO 2025

Udhayvir Singh Grewal, MD
A medication bottle with a red cap on a pharmacy counter, blurred pharmacy shelves in the background.

Article

10/21/2025

Over The Counter Medication: A Game-Changer for PI3K-Altered Colorectal Cancer?

Sawyer Bawek, DO
Berlin cityscape at dusk with the TV Tower, historic buildings, and river, highlighting oncology research and medical innovation in Germany for oncology updates and cancer treatment advancements.

Article

10/17/2025

The 12 Most Anticipated Practice-Changing Abstracts at ESMO 2025: Community Oncologist’s Guide

Sawyer Bawek, DO
Immune cells attacking cancer cells in the bloodstream, illustrating cancer immunotherapy and blood cancer treatment strategies.

Article

10/09/2025

Real-World Evidence Supports Outpatient Axicabtagene Ciloleucel (Yescarta) Administration for Relapsed/Refractory LBCL

Sawyer Bawek, DO
Microscopic view of cancer cells with surrounding blood cells and immune response, illustrating recent oncological updates and advancements in cancer research.

Article

08/26/2025

Updates in Breast Cancer From ASCO 2025

Zunairah Shah, MD
Uncancerous blood cells and white blood cells circulating in a blood vessel for medical research and oncology updates.

Article

08/15/2025

The Impact of Novel Agents in Non-Hodgkin Lymphoma Treatment

Anuja V. Abhyankar, MD
Malignant cell division illustration showing cancer cells attacking the human immune system and bloodstream, emphasizing oncology research and targeted cancer therapies.

Article

07/28/2025

Management of Multiple Myeloma: From Newly Diagnosed to Relapsed/Refractory Disease

Vaishali Deenadayalan, MD
Lung anatomy with highlighted bronchi and surrounding structures in a digital medical illustration.

Article

07/28/2025

Thoracic Oncology in 2025: Evolving Standards and Practice-Changing Data From ASCO

Kriti Ahuja, MD
OncUpdates conference panel discussion featuring medical professionals discussing oncology advancements and cancer treatment strategies at a professional medical event.

Article

07/02/2025

Breakthroughs in Bladder, Prostate, and Kidney Cancer: What Oncologists Need to Know From ASCO 2025

Saad Atiq, MD
Microcancer cells in human bladder illustrating cancer biology and urology research.

Article

06/30/2025

Durvalumab Enters the Perioperative Landscape in Muscle-Invasive Bladder Cancer: Reflections from the NIAGARA Trial and ASCO 2025 Updates

Charbel Matar, MD

Article

06/11/2025

Advancements in Oncology at ASCO 2025: Breast Cancer Highlights

Tanmayi Pai, MD
Discussion panel at a medical conference with professionals in a modern cityscape setting, focused on oncology updates and research advancements.

Article

06/10/2025

Shifting Paradigms in Lung Cancer Care: Insights From ASCO 2025

Maria A. Velez, MD, MS
Expert medical professionals discuss cancer treatment advances at an oncology conference, emphasizing personalized medicine and innovative research in cancer care.

Article

06/10/2025

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

Seyi Abidoye, MBBSLisa Liu, MD
Enhanced visualization of the human digestive system highlighting the stomach and intestines for medical and anatomical research.

Article

06/03/2025

ASCO 2025 Highlights: Breakthroughs in GI Oncology From BREAKWATER, MATTERHORN, ATOMIC & CHALLENGE

Sawyer Bawek, DO
Detailed 3D rendering of human lungs showing the bronchial tubes, arteries, and veins for educational medical or respiratory health content.

Article

05/28/2025

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Sawyer Bawek, DO
Lung cancer illustration showing tumor growth inside the lung with detailed respiratory system anatomy.

Article

05/26/2025

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

Sawyer Bawek, DO
Innovative medical conference with healthcare professionals discussing oncology treatments and latest cancer research advancements in a modern venue.

Article

05/23/2025

Advances in Managing CNS Metastases in Breast Cancer: SABCS 2024 Insights

Hetal Mistry, MD

Events

View Events
Clinicals to Exam: Hematology in New Orleans, LA

Clinicals to Exam: Hematology in New Orleans, LA

December 12, 2026

This program, coinciding with ASH 2026 in New Orleans, is designed to equip fellows with essential knowledge and...

Advancements in Oncology: ASH in New Orleans, LA

Advancements in Oncology: ASH in New Orleans, LA

December 12, 2026

Join the Oncology Brothers and leading experts in New Orleans for an exclusive live event exploring how new...

Advancements in Oncology: SABCS in San Antonio, TX

Advancements in Oncology: SABCS in San Antonio, TX

December 8, 2026

Join the Oncology Brothers and leading experts in San Antonio for an exclusive live event exploring how new...

Advancements in Oncology: ASCO GI in San Francisco, CA

Advancements in Oncology: ASCO GI in San Francisco, CA

January 21, 2027

Join the Oncology Brothers and leading experts in San Francisco for an exclusive live event exploring how new...